Friday April 17th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
16:00 - 17:30 h.
16:00 – 17:30
Auditorium A
Track: Training in Dual
Diagnosis
Debate Forum - DF01
DUAL DISORDERS IN SCIENTIFIC JOURNALS
Chair:
Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine –
University of Miami. FL, USA.
Speakers:
JOURNAL OF DUAL DIAGNOSIS
Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA.
REVISTA DE PATOLOGÍA DUAL
Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid,
España.
EUROPEAN ADDICTION RESEARCH
Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The
Netherlands.
ACTAS ESPAÑOLAS DE PSIQUIATRÍA
Miquel Roca, Universidad de las Islas Baleares. Mallorca, España.
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS
Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital,
Pisa, Italy.
ADVANCES ON DUAL DIAGNOSIS
Gail Gilchrist, King's College London, United Kingdom.
16:00 – 17:30
Auditorium B
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Symposium – SY01
TREATMENT OF DUAL DISORDERS IN ADOLESCENTS AND YOUNG ADULTS WITH
PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH
Chair:
Daniela Polese, University "Federico II" of Naples, Italy.
Speakers:
THE POSSIBILITY OF TREATING DUAL DISORDERS IN YOUNG POPULATION THROUGH
PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH
Daniela Polese, University "Federico II" of Naples, Italy.
SEVERE MENTAL ILLNESSES, DUAL DIAGNOSIS AND VIOLENCE: A PSYCHOTHERAPEUTIC
PROSPECTIVE FOR FORENSIC PSYCHIATRY
Niccolò Trevisan, Italian Society of Criminology, Italy.
PSYCHOTHERAPY PRACTICE OF DUAL PSYCHOPATHOLOGY IN YOUNG IN A COOPERATIVE
SERVICE OF MEDICAL PSYCHOTHERAPY
Piera Galeandro, Cooperativa Sociale di Psicoterapia Medica, Italy.
PRELIMINARY DATA FROM AN EARLY DETECTION STUDY CONDUCTED IN CHILD AND
ADOLESCENT COMMUNITY CENTERS
Paolo Fiori, "Sapienza" Università di Roma, Italy.
16:00 – 17:30
Room 1
Track: Behavioral
addictions /
Gambling Disorders
Symposium – SY02
IS EMOTIONAL DEPENDENCE A BEHAVIORAL ADDICTION WITHIN DUAL DISORDERS?
Chair:
Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España.
Speakers:
FRAMEWORK OF EMOTIONAL BEHAVIORAL ADDICTION UNIT AND WITHIN THE RANGE OF
DUAL DIAGNOSIS
www.cipd2015.com
Pág. 1
Friday April 17th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Mª Nieves Gómez, Ayuntamiento San Sebastian de los Reyes, Madrid, España.
EMOTIONAL DEPENDENCY IN DAILY PRACTICES OF FAMILY PHYSICIANS: INTERVENTION
AND BIOLOGISTIC BASIS
Juan A. López, Hospital 12 de Octubre, CS Las Calesas, Madrid, España.
TRANSVERSAL EMOTIONAL DEPENDENCY TREATMENT IN A THERAPEUTIC COMMUNITY
FOR DUAL PATIENTS
16:00 – 17:30
Room 2-3
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium - SY03
BIOMARKERS IN DUAL DISORDERS
Chair:
Magi Farré, Institut Hospital del Mar d'Investigacions Mèdiques-IMIM, Universitat Autònoma
de Barcelona, España.
Speakers:
BIOMARKERS IN PSYCHIATRY: AN OVERVIEW
Rocío Martín-Santos, Institute of Neurosciences, Hospital Clínic, IDIBAPS, CIBERSM, España.
ARE CYTOKINES BIOLOGICAL MARKERS OF DUAL DIAGNOSIS?
Fernando Rodriguez de Fonseca, Instituto IBIMA, Hospital Carlos Haya de Málaga, España.
NEW BIOINFORMATIC TOOL FOR SUPPORTING BIOMARKERS IDENTIFICATION FOR
PSYCHIATRIC DISORDERS: PSYGENET
Laura Furlong, Institut Hospital del Mar d'Investigacions Mèdiques. Barcelona, España.
16:00 – 17:30
Room 4
Track: Depression
Symposium - SY04
DUAL DISORDERS IN KETAMINE ADDICTION
Chair:
Wai Kwong Tang, The Chinese University of Hong Kong, China.
Speakers:
PSYCHIATRIC MORBIDITY IN KETAMINE USERS
Wai Kwong Tang, The Chinese University of Hong Kong, China.
THE DIFFERENTIAL ROLES OF PSYCHOSOCIAL RISKS BETWEEN KETAMINE USERS AND BETEL
BUT CHEWERS IN TAIWAN
Kun-Hua Lee, Kao Yuli Hospital, Ministry of Health and Welfare, Taiwan.
16:00 – 17:30
Room 5
Track: Bipolar Disorders
Symposium - SY05
BIPOLARITY AND ADDICTIVE DISORDERS
Chair:
Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú.
Speakers:
BIPOLARITY AND COCAINE TO THE BRAIN SPECT
Agata Salazar, Universidad Peruana Cayetano Heredia. Lima, Perú.
PREVALENCE AND BIPOLAR CLINIC
Carlos Ordoñez, Hospital Hermilio Valdizan. Lima, Perú.
DUAL DIAGNOSIS NEUROTOXIC THEORY
Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú.
16:00 – 17:30
Room 6
Track: Personality
Symposium - SY06
COGNITIVE NEUROSCIENCE APPLIED TO PERSONALITY DISORDERS AND PSYCHOPATHY
Chair:
www.cipd2015.com
Pág. 2
Friday April 17th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Disorders
Guillermo N. Jemar, Hospital Borda, Asociación Neuropsiquiátrica Argentina, Argentina.
Speakers:
NEUROBIOLOGY OF ANTISOCIAL BEHAVIOR AND NEUROBIOLOGICAL APPROACHES TO
PSYCHOPATHOLOGY
Martin Mazzoglio y Nabar, Asociación Neuropsiquiátrica Argentina - Servicio Penitenciario
Federal Argentina, Argentina.
THE ETHICAL AND LEGAL ASPECTS IN PERSONALITY DISORDERS AND PSYCHOPATHY
Ramiro Isla, Asociación Neuropsiquiátrica Argentina - Defensoría General de La Nación,
Argentina.
16:00 – 17:30
Room 7
Track: Post-Traumatic
Stress
Symposium - SY07
LATEST DEVELOPMENTS IN SIMULTANEOUS TREATMENT OF TRAUMA AND ADDICTION
Chair:
Ayna Johansen, Norwegian Centre for Addiction Research, University of Oslo, Norway.
Speakers:
CONCURRENT TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND ALCOHOL
DEPENDENCE IN WOMEN IN A SWEDISH SETTING - A PILOT STUDY
Anna Persson, Karolinska Institutet. Solna, Sweden.
A RATIONALE FOR EMOTION-FOCUSED TREATMENT FOR COMORBID SUBSTANCE USE
DISORDER AND POST-TRAUMATIC STRESS
Shedeh Tavakoli, Northeastern Illinois University, Chicago. IL, USA.
THERAPIST EXPERIENCES AND TRAINING NEEDS FOR TREATING SIMULTANEOUS TRAUMA
AND ADDICTION
Ingerid E. Bjelland, Frogn Kommune, Norway.
16:00 – 16:45
Room 8
Track: Useful
Psychotropic Drugs
Main Lecture - ML01
DRUGS AS MEDICATIONS IN DUAL DISORDERS
Chair:
Carlos Roncero, Universidad Autónoma de Barcelona, España.
Speaker:
Rafael Maldonado, Universidad Pompeu Fabra. Barcelona, España.
16:45 – 17:30
Room 8
Track: Psychosis
Main Lecture - ML02
ARE EXISTING PSYCHIATRIC DIAGNOSES ABLE TO DESCRIBE DUAL DISORDERS IN
THE LIGHT OF A WIDENING COMORBIDITY?
Chair:
José M. Goikolea, Hospital Clinic, Barcelona, España.
Speaker:
Pier Maria Furlan, Dept. of Mental Health and Drug Abuse, Turin, Italy.
16:00 – 17:30
Room 9
Track: Child &
Adolescent Psychiatry
www.cipd2015.com
Symposium - SY08
ENHANCING CARE FOR ADOLESCENTS WITH DUAL DISORDERS: OUTREACH PREVENTION
EFFORTS, PEDIATRIC HEALTH EVALUATIONS AND SUICIDAL RISK ASSESSMENT
Chair:
Pág. 3
Friday April 17th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA.
Speakers:
CANNABIS HEALTH RISKS AND PREVENTION PROGRAMS
Mònica Prat, Hospital Universitari Vall d'Hebron. Barcelona, España.
PEDIATRIC HEALTH EVALUATION
Donald E. Greydanus, Western Michigan Univ. SchooloOf Medicine, Kalamazoo. MI, USA.
SUICIDAL RISK ASSESSMENT
Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA.
16:00 – 16:45
Room 10
Track: Multidisciplinary
Intervention in Dual
Disorders
Workshop - WS01
ASSERTIVE OUTREACH SERVICES IN DUAL DISORDERS. STATE OF THE ART, AND THE
NORWEGIAN SOLUTION IN COMMITTED, COMMUNITY COLLABORATION - THE C-FLEX
MODEL
Chair:
Bror Just Andersen, Baerum DPC, Veste Viken HT, Norway.
Speakers:
INTERDISCIPLINARY ASSERTIVE OUTREACH TEAMS IN DUAL DISORDERS - STATE OF THE
ART
Lars Linderoth, Vestre Viken HT/Baerum DPC, Norway.
THE DEVELOPMENT, EXPERIENCE AND SUCCESS FACTORS WITH THE C-FLEX TEAM
Kjetil Emilsen, Vestre Viken HT/Baerum DPC, Norway.
THE WAY AHEAD - ESTABLISHING A C-FLEX YOUTH TEAM
Aslak Woien Augedal, Vestre Viken HT/ Division of Mental Health And Addiction, Norway.
METHODICAL APPROACH AND RESULTS OF THE EFFECT EVALUATION OF THE C-FLEX TEAM THREE YEARS OF MODEL TESTING
Bror Just Andersen, Baerum DPC, Veste Viken HT. Norway.
16:45 – 17:30
Room 10
Track: Personality
Disorders
Workshop - WS02
THE USE OF EAR ACUPUNCTURE TO AID IN RETENTION OF THOSE WITH BORDERLINE
PERSONALITY DISORDER IN SUBSTANCE ABUSE TREATMENT
Chair/Speaker:
Elizabeth B. Stuyt, Colorado Mental Health Institute at Pueblo, Pueblo. CO, USA.
16:00 – 16:45
Room 11
Track: Training in Dual
Diagnosis
Symposium – SY09
PROTOCOLS OF INTERVENTION IN DUAL PATHOLOGY
Chair:
Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio
Marañón. Madrid, España.
Speakers:
Carlos Roncero, Universidad Autónoma de Barcelona, España.
José Martínez-Raga, Unidad de Conductas Adictivas de Gandía, CEU Cardenal Herrera.
Valencia, España.
www.cipd2015.com
Pág. 4
Friday April 17th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
16:45 – 17:30
Room 11
Special Lecture – SL01
DUAL PATHOLOGY AND ART
Co-organized by the Foundation on Dual Disorders
Chair:
Lara Grau-López, Hospital Universitari Vall d’Hebron. Barcelona, España.
Speaker:
J. Ramon Pigem, Clínica Bellavista, Lleida, España.
16:00 – 17:30
Room 12
Oral Communications - OC01
Chairs:
José Antonio Navarro, Hospital Universitario Vall d’Hebron de Barcelona/Clínica Galatea.
Barcelona, España.
Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay.
EXECUTIVE FUNCTIONING, SUICIDE ATTEMPTS AND SUBSTANCE RELAPSES IN PATIENTS
WITH AND WITHOUT PSYCHIATRIC COMORBIDITY
1
1
1
1
1, 2
I. Benaiges , S. López-Vera J. E. Marquez-Arrico , G. Prat , A. Adan
1
Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona,
España.
2
Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España.
CANNABIS: SU INFLUENCIA A LO LARGO DE UN AÑO EN LOS INTENTOS DE SUICIDIO
1,2
1
1
1
2
M. Canal Rivero , A. Yañez Castro , G. Benítez Rodriguez , J. García Egea , Jordi E. Obiols ,
1,3
M. Ruiz Veguilla
1
Hospital Universitario Virgen del Rocío. Sevilla, España.
2
Facultat de Psicología. Departament de Psicología Clínica i de la Salut. Universitat
Autònoma de Barcelona, España.
3
Instituto de Biomedicina de Sevilla (IBIS), España.
PERSONALITY DISORDERS, SUBSTANCE USE DISORDER AND CRIMINAL BEHAVIOR
Anna C. S. Chaves
University of São Paulo, São Paulo, Brasil.
PERIPHERAL TEMPERATURE CIRCADIAN RHYTHM IN PATIENTS WITH DUAL DIAGNOSIS:
MENTAL DISORDER AS A MODULATING FACTOR
1
1
2
1,3
S. López-Vera , I. Benaiges , J.A. Madrid , A. Adan
1
Department of Psychiatry and Clinical Psychobiology, University of Barcelona, España.
2
Chronobiology Laboratory, Department of Physiology, University of Murcia, España.
3
Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España.
THE CO-MORBIDITY BETWEEN SUICIDE VICTIMS IN THE DISTRICT OF TIRANA, OVER THE
TIME PERIOD 2001-2010
1
1
3
Pasho Maksuti , Vuksan Kola , Artan Simaku
1
UHC (University Hospital Centre) “Mother Theresa”, Tirana, Albania.
www.cipd2015.com
Pág. 5
Friday April 17th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
2
Institute of Public Health, Tirana, Albania.
FOCUS GROUPS: A METHOD FOR DEVELOPING GUIDELINES FOR DUAL DIAGNOSIS
1
2
3
4
F. Matthys , P. Joosten , W. van den Brink , B. Sabbe
1
University Hospital Brussels and Vrije Universiteit Brussels (VUB), The Netherlands.
2
Psychiatric Centre Broeders Alexianen, Tienen, Belgium.
3
Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical
Center,University of Amsterdam, Amsterdam, The Netherlands.
4
Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp,
Antwerp, Belgium.
ADDICTION AND MENTAL PRODUCTIONS IN TRAUMATIC PATHOLOGIES
1
2
Freddy nyegue , Mlle Laurine Fort
1
Centre Psychothérapique de Laxou/ Nancy, France.
2
Université de Lorraine, France.
THE EFFECT OF ACADEMIC SELF-EFFICACY AND SELF-AWARENESS ON ACADEMIC
ACHIEVEMENT IN STUDENTS WITH LEARNING DISABILITY (LD)
Moluk Khademi Ashkezari, Salehe Piryaei
Alzahra University, Tehran, Iran.
17:30 - 18:30 h.
17:30 – 18:30
Auditorium A
Track: Opioid System
and Dual Disorders
www.cipd2015.com
Plenary Session - PS01
TREATMENT AND 42-MONTH FOLLOW-UP OF PRESCRIPTION OPIOID DEPENDENCE: THE
ROLE OF DUAL DISORDERS
Chair:
Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron.
Barcelona, España.
Speaker:
Roger Weiss, Harvard Medical School/division of Alcohol and Drug Abuse, McLean Hospital,
Belmont. MA, USA.
Pág. 6
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
08:30 – 10:00 h.
08:30 – 10:00
Auditorium A
Track: Attention Deficit
Symposium – SY10
MANAGEMENT OF SUBSTANCE USE DISORDERS IN PATIENTS WITH ADHD
Chair:
Josep A. Ramos-Quiroga, Hospital Universitari Vall d'Hebron. Barcelona, España.
Speakers:
TREATMENT OF COCAINE DEPENDENCE IN ADULTS WITH ADHD
Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA.
ADHD MEDICATION USE AND MISUSE IN ADOLESCENCE
Geurt van de Glind, Amsterdam Institute for Addiction Research. Amsterdam, The
Netherlands.
TRAUMA IN SUD PATIENTS WITH AND WITHOUT ADHD
Maija Konstenius, Department of Clinical Neuroscience, Division of Psychiatry, Karolinska
Institutet. Solna, Sweden.
IS THE METHYLXANTHINE'S CONSUMPTION INCREASED IN ADULTS WITH ADHD?
Josep A. Ramos-Quiroga, Hospital Universitari Vall d'Hebron. Barcelona, España.
08:30 – 10:00
Auditorium B
Track: Spirituality and
Dual Disorders
Debate Forum - DF02
TRASCENDENCE OF SPIRITUALITY AND DUAL DISORDERS
Chair:
Adolf Tobeña, Catedrático de Psiquiatría y Psicología Médica. Universitat Autònoma de
Barcelona, España.
Speakers:
SELF-HELP AND SPIRITUALITY
Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España.
INTERVIEW ON SPIRITUALITY IN DUAL PATIENTS
Jaime Roig, Centre Medic Alella. Barcelona, España.
08:30 – 09:15
Room 1
Track: Training in Dual
Diagnosis
Main Lecture - ML03
DUAL DISORDERS IN THE JOURNAL ADDICTION
Chair:
Miquel Roca, Universidad de las Islas Baleares. Mallorca, España.
Speaker:
Robert West, Health Behavior Research, Department of Epidemiology, University College
London, United Kingdom.
09:15 – 10:00
Room 1
Track: Basic Research
Main Lecture - ML04
DELAYED GRATIFICATIONS AND DUAL PATHOLOGIES: THE PRICE OF MODERNITY
Chair:
Joan Colom, Agència de Salut Pública de Catalunya, España.
Speaker:
Ruben Baler, National Institute on Drug Abuse, Bethesda. MD, USA.
www.cipd2015.com
Pág. 7
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
08:30 – 10:00
Room 2-3
Track: Cannabis and
Dual Disorders
Invited Symposium - IS01
THE ONGOING DEBATE: CANNABIS AND DUAL DISORDERS
Chair:
Amine Benyamina, Centre d'Enseignement, de Recherche et de Traitement des Addictions.
Paris, France.
Speakers:
CANNABIS ABUSE AND SHORT PSYCHOTIC EPISODES
Mehdi Paes, Mohamed V Universityin Rabat, Morocco.
CANNABIS USE IN CHRONIC SCHIZOPHRENIA PATIENTS
Carmen Barral, Hospital Universitari Vall d'Hebron. Barcelona, España.
CANNABIS AND OTHER DRUGS: USE AMONG DUAL DISORDERS PATIENTS WITH PERSIST
MENTAL ILLNESS. A 7 YEARS LONGITUDINAL FOLLOW-UP STUDY
Kim T. Mueser, Boston University, USA.
08:30 – 10:00
Room 4
Track: Personality
Disorders
Symposium - SY11
RELEVANCE OF SUBSTANCE USE DISORDERS (SUD) IN A LONG LIFESPAN: PROGRAM OF TPL
BARCELONA GROUP
Chair:
Marc Ferrer, Hospital Universitari Vall d'Hebron. Barcelona, España.
Speakers:
THE IMPORTANCE OF SUBSTANCE USE DISORDER IN A PROGRAM FOR THE BORDERLINE
PERSONALITY DISORDER (BPD) THROUGHOUT LIFE
Mercè Gibert, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona,
España.
THE IMPORTANCE TO TREAT THE SUBSTANCES USE DISORDER COMORBIDITY
Joan Vegué, Universitat Autònoma de Barcelona, Servei de Psiquiatria en Hospital Vall
d'Hebron. Barcelona, España
SUBSTANCE USE DISORDERS (SUD) IN BORDERLINE PERSONALITY DISORDER (BPD):
INFLUENCE AT CLINICAL MANIFESTATION
Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona,
España.
08:30 – 10:00
Room 5
Track: Transcultural
Psychiatry
Invited Symposium - IS02
DUAL DISORDERS IN THE MODERN WORLD: TRANSCULTURAL APPROACH
Chair:
Dinesh Bhugra, King’s College London, United Kingdom.
Speakers:
CULTURAL INTERVIEW IN DUAL PATIENTS
Francisco Collazos, Hospital Universitari Vall d'Hebron, Barcelona, España.
IMMIGRATION, SOCIAL PSYCHIATRY AND DUAL PATHOLOGY
Dinesh Bhugra, King’s College London, United Kingdom.
IS DUAL DISORDER DIFFERENT IN LATIN POPULATIONS AMONG LATINOS IN USA?
Margarita Alegria, Center for Multicultural Mental Health Research, Cambridge Health
Alliance & Harvard Medical School, Somerville. MA, USA.
www.cipd2015.com
Pág. 8
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
08:30 – 10:00
Room 6
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium - SY12
BIOLOGICAL RHYTHMS AND DUAL DISORDERS. A NON NEGLIGIBLE CONNECTION
Chair:
Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de
Barcelona, España.
Speakers:
CHRONOBIOLOGY AND DUAL DISORDERS. THE CURRENT STATE OF KNOWLEDGE
Sílvia López-Vera, Universitat de Barcelona. Barcelona, España.
RHYTHMIC IMPAIRMENT AND MODULATING FACTORS IN PATIENTS WITH DUAL
DIAGNOSIS
Irina Benaiges, Universitat de Barcelona. Barcelona, España.
CLINICAL IMPLICATIONS OF RHYTHMIC IMPAIRMENT IN SUBSTANCE USE DISORDERS AND
DUAL DIAGNOSIS
Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de
Barcelona, España.
08:30 – 10:00
Room 7
Track:
Psychopharmacological
Treatments in Dual
Disorders
Debate Forum - DF03
DRUGS FOR USE IN CONDITIONS DIFFERENT TO THOSE AUTHORIZED IN DUAL DISORDERS:
CONSENSUS OF THE SEPD
Chair:
Francisco J. Álvarez, Institute for The Study of Alcohol and Drugs, Universidad de Valladolid,
España.
Speakers:
CONSENSUS OF SEPD ON DUAL BIPOLAR DISORDER TREATMENT
Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM.
Valencia, España.
CONSENSUS OF SEPD ON DUAL DISORDER ANXIETY TREATMENT
Marisa Dorado, Unidad de Conductas Adictivas De Gandía. Valencia, España.
CONSENSUS OF SEPD ON DUAL DISORDER DEPRESSION TREATMENT: PRELIMINARY
PROPOSAL OF THE WORKING GROUP
Pablo Vega, Instituto de Adicciones. Madrid, España.
08:30 – 10:00
Room 8
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Debate Forum - DF04
HOW TO STOP THE TRAIN BEFORE IT CRUSHES OR DERAILS? ASSESSMENT AND
PREVENTION OF DUAL PATHOLOGY IN ADOLESCENCE
Chair:
Rosa Fernández-Marcote, UCA de Toledo, Hospital Provincial, SESCAM. Toledo, España.
EFFECTIVE PSYCHOLOGICAL INTERVENTIONS IN ADOLESCENTS WITH DUAL PATHOLOGY.
FROM PREVENTION TO TREATMENT
Lorena Casete, Unidad Asistencial de Drogodependencias. ACLAD. A Coruña, España.
DUAL TEENS
Raquel Vidal, Hospital Universitari Vall de Hebrón. Barcelona, España.
WHAT ABOUT "OUR" TEENS? CODEPENDENCIES AND RISKS
Angel M. Turbi, Universidad Católica de Valencia. S Vicente Mártir. Valencia, España.
PSYCHOMETRIC EVALUATION TOOLS IN DUAL PATHOLOGY
www.cipd2015.com
Pág. 9
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d’Hebron, Barcelona,
España.
08:30 – 10:00
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
08:30 – 10:00
Room 10
Track: Alcohol
Symposium - SY13
NOVEL APPROACHES TO UNDERSTANDING AND TREATING COMORBID DEPRESSION AND
ALCOHOL MISUSE
Chair:
Marie-Eve Couture, Dalhousie University. Halifax, Canada.
Speakers:
A QUALITATIVE STUDY OF DRINKING TO COPE WITH DEPRESSION
Marie-Eve Couture, Dalhousie University. Halifax, Canada.
CONTEXT COUNTS: SOLITARY DRINKING EXPLAINS THE ASSOCIATION BETWEEN
DEPRESSIVE SYMPTOMS AND ALCOHOL-RELATED PROBLEMS
Matthew Keough, Concordia University. Montréal, Canada.
THE EFFECTS OF DEPRESSION LEVEL AND ALCOHOL ADMINISTRATION ON POSITIVE AND
NEGATIVE POST-EVENT RUMINATION: AN EXPERIMENTAL STUDY
Sherry H. Stewart, Dalhousie University. Halifax, Canada.
INTERVENING WITH HOPELESSNESS REDUCES AND PREVENTS DEPRESSION AND ALCOHOL
MISUSE IN ADOLESCENTS
Patricia Conrod, Université de Montréal, Canada.
08:30 – 09:15
Room 11
Track: Epidemiology and
Dual Disorders
Main Lecture - ML05
CORMORBIDITY OF SUBSTANCE AND PSYCHIATRIC DISORDERS: EPIDEMIOLOGIC FINDINGS,
NEW DIRECTIONS
Chair:
Pere Bonet, Pere Bonet Gabinet Psiquiatria i Psicologia Clínica, Manresa. Barcelona, España.
Speaker:
Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA.
09:15 - 10:00
Room 11
Track: Child &
Adolescent Psychiatry
Workshop - WS03
ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL DISORDERS:
DIFFERENTIAL DIAGNOSTIC CHARACTERISTICS
Chair:
Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y
sus Familias. Barcelona, España.
Speakers:
ADOPTED AND NON-ADOPTED ADOLESCENTS: CRITERIA FOR RESIDENTIAL ADMISSION TO
SPECIALISED HEALTHCARE FACILITIES
Ramon Martí, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y
sus Familias. Barcelona, España.
COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED ADOLESCENTS AND
www.cipd2015.com
Pág. 10
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
YOUNG ADULTS AT SPECIALISED HEALTHCARE CENTRES
Cristina Baliarda, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes,
Jóvenes y sus Familias. Barcelona, España.
08:30 – 10:00
Room 12
Oral Communications - OC02
Chairs:
Nicolás Ramírez, Hospital Sant Rafael, Barcelona, España.
Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico.
TIME TREND ANALYSIS OF PATIENTS WITH DUAL SEEKING TREATMENT FROM DUAL
DIAGNOSIS CLINIC OF A TERTIARY CARE SUBSTANCE USE DISORDER TREATMENT CENTRE
IN INDIA
Y.P.S.Balhara, R. Gupta, R. Lal
India Institute of Medical Sciences (AIIMS), New Delhi, India.
PERPETRATOR OF FACTITIOUS DISORDER ON ANOTHER RECEIVES AN INTERNAL SELFREWARD IN THE MEDICAL ENVIRONMENT. ADDICTIVE BEHAVIOR?
1
1
2
M. López-Rico , J. López-Sánchez López J. , J.L. Jiménez Hernández
1
Facultad de Medicina. Universidad de Salamanca, España.
2
Hospital "Doce de Octubre". Madrid, España.
PSYCHIATRIC DISORDERS AND HIV-HCV COINFECTION: NEED FOR BETTER SCREENING AND
CONTINUOUS CARE
1
2
3
2
4
3
5
L. Michel , M. Winnock , C. Protopopescu , M.A. Loko , J.P. Lang , B. Spire , D. Salmon , F.
3
3
Dabis , M.P. Carrieri
1
Centre Pierre Nicole; Inserm, U669, Paris, France.
2
Inserm, U897, ISPED, Bordeaux, France.
3
Inserm, (SESSTIM), Marseille, France.
4
CHRU Strasbourg, Strasbourg, France.
5
Hôpital Cochin Port-Royal, Paris, France.
A BROAD UNDERSTANDING OF GAMING ADDICTION: GAMERS’ THOUGHTS, PERCEPTIONS
AND BEHAVIOURS IN GAME TRANSFER PHENOMENA
A. Ortiz de Gortari, M.D Griffiths
Nottingham Trent University, Nottingham, United Kingdom.
DRUG AND SYMPTOMS OF PATHOLOGICAL GAMBLING IN COLOMBIAN PRISON
POPULATION
J. Ruíz Pérez, O. Garay Quevedo, L. Rueda Useche
Facultad de Ciencias Humanas, Universidad Nacional de Colombia, Bogotá, Colombia.
DETERMINE THE EFFECT OF TREATMENT ON RETENTION AMONG DRUG USERS
Peymaneh Shirinbayan, Hassan Rafiey, Afshin Vejdani Roshan, Asghar dadkhah, Ali
Farhoudian
www.cipd2015.com
Pág. 11
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
University of Social welfare and rehabilitation sciences, Tehran, Iran.
AUTISM SPECTRUM DISORDERS IN DUAL-DIAGNOSIS PATIENTS – PREVALENCE STUDY
CONDUCTED AT A DUAL DIAGNOSIS TREATMENT FACILITY
1
1
2
3
A.E. Bonebakker , S. van Nieuwerk , R. Vuijk , P. Blanken
1
Palier Centre for Dual Disorders, The Hague, The Netherlands.
2
Sarr Expertise Centre of expertise in autism, Rotterdam, The Netherlands.
3
Parnassia Addiction Research Centre, The Hague, The Netherlands.
DSM-IV DIAGNOSES AMONG A COMMUNITY SAMPLE OF CHINESE ADOLESCENTS: RATES
AND PATTERNS OF COMORBIDITY
Patrick Leung
The Chinese University Of Hong Kong, China.
SYSTEMS OF CARE FOR DUAL DISORDERS: THE CANADIAN EXPERIENCE
N. El-Guebaly
University of Calgary, Alberta, Canada.
10:00 – 12:00 h.
SATELLITE Symposium
10:00 – 12:00
Room 1
Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00
Room 2-3
Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00
Room 6
Industry Session not included in official scientific programme CME/CPD
SATELLITE Symposium
SATELLITE Symposium
12:00 – 14:00 h.
12:00 – 14:00
Room 1
SATELLITE Symposium
Industry Session not included in official scientific programme CME/CPD
12:00 – 14:00
Room 2-3
SATELLITE Symposium
Industry Session not included in official scientific programme CME/CPD
12:00 – 14:00
Room 11
Supported WORKSHOP
Industry Session not included in official scientific programme CME/CPD
www.cipd2015.com
Pág. 12
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
14:00 – 15:30 h.
14:00 – 15:30
Auditorium A
Track: Tobacco
Invited Symposium - IS03
SMOKE IN YOUR EYES
Chair:
Robert West, Health Behavior Research, Department of Epidemiology, University College
London, United Kingdom.
Speakers:
DEPRESSION AND ADDICTION, DOES TOBACCO AFFECT
Eugeni Bruguera, Hospital Universitari Vall d'Hebron. Barcelona, España.
TREATMENT OF TOBACCO DEPENDENCE AND ITS INFLUENCE ON OTHER ADDICTIONS
Robert West, Health Behavior Research, Department of Epidemiology, University College
London, United Kingdom.
CHOLINERGIC SYSTEM AND TOBACCO AND DUAL DISORDERS
Manuel Gurpegui, Universidad de Granada, España.
14:00 – 15:30
Auditorium B
Track: Personality
Disorders
Debate Forum - DF05
PERSONALITY FEATURES OR PERSONALITY DISORDERS: DOES IT MATTER IN DUAL
DISORDERS?
Chair:
Jose L. Carrasco, Universidad Complutense de Madrid, España.
Speakers:
THERAPEUTIC STRATEGIES OF SUBSTANCE USE DISORDER WITH COMORBIDITY OF
BORDERLINE PERSONALITY DISORDER
Miquel Gasol, Psiquiatría y Psicología del Hospital General de Catalunya. Barcelona, España.
TRAITS, TROUBLES AND SUBSTANCE USE
Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàtel, Switzerland.
THE IMPORTANCE OF (SUBSTANCE USE DISORDER) SUD IN THE COMPLEX PATHOGENESIS
OF (BORDERLINE PERSONALITY DISORDER) BPD
Marc Ferrer, Hospital Universitari Vall d'Hebron. Barcelona, España.
14:00 – 15:30
Room 1
Track: Basic Research
Invited Symposium - IS04
ARE GENETICS RISK FACTORS FOR DUAL DISORDERS?
Chair:
Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment
Research Center. PA, USA.
Speakers:
CANNABIS USE AND SCHIZOPHRENIA FROM THE PERSPECTIVE OF THE GENETIC FACTORS
Araceli Rosa, Universidad de Barcelona, España.
GENETIC RISK FACTORS FOR DRUG ADDICTION
Noelia Fernández, Genetics Department, UB. CIBERER. Barcelona, Spain.
POLYMORPHISMS AND THE EFFICACY OF METHADONE
Francina Fonseca, Hospital del Mar. Barcelona, España.
www.cipd2015.com
Pág. 13
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
14:00 – 15:30
Room 2-3
Track: Cannabis and
Dual Disorders
Invited Symposium - IS05
CANNABIS, PSYCHOSIS AND DUAL DISORDERS
Chair:
Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA.
Speakers:
FIRST PSYCHOTIC EPISODES; CANNABIS AND DUAL PATHOLOGY
Luis San, Hospital Sant Joan de Deu. Barcelona, España.
EVALUATION OF CANNABIS CONSUMPTION IN PSYCHOTIC DUAL PATIENTS
Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA.
USE OF CANNABIS AND ITS INFLUENCE IN ON DEVELOPMENT
Miguel Ruiz-Veguilla, Hospital Virgen del Rocío. Sevilla, España.
14:00 – 15:30
Room 4
Track: Training in
Dual Diagnosis
Symposium – SY14
THE CONVERGENCE OF ADDICTION MEDICINE AND DUAL DISORDERS
Session in collaboration with ISAM, ACAPI and SEPD
Chair:
Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA.
Speakers:
Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio
Marañón. Madrid, España.
Nady El-Guebaly, University of Calgary. Alberta, Canada.
Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina.
14:00 – 15:30
Room 5
Track: Evaluation
processes in Dual
Disorders
Symposium - SY15
NEUROPSYCHOLOGICAL PERFORMANCE ON DUAL DISORDERS
Chair:
Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de
Barcelona, España.
Speakers:
NEUROPSYCHOLOGICAL IMPACT OF DUAL DISORDERS. CURRENT KNOWLEDGE
Gemma Prat, Universitat de Barcelona, España.
NEUROPSYCHOLOGICAL ASSESSMENT IN DUAL DISORDER PATIENTS. SELECTING TASKS TO
OPTIMIZE THE EVALUATION
Carlos Jacas, Hospital Universitari Vall d'Hebron. Barcelona, España.
NEUROCOGNITIVE PERFORMANCE OF DUAL SCHIZOPHRENIA: A POSSIBLE BIOMARKER
Irina Benaiges, Universitat de Barcelona, España.
14:00 – 15:30
Room 6
Track: Psychosis
Symposium – SY16
FETAL ALCOHOL SPECTRUM DISORDER AS A GENERATOR OF DUAL PATHOLOGY
Chair:
Montse Pàmias, Corporació Sanitaria I Unviersitari Parc Taulí, Sabadell. Barcelona, España.
Speakers:
EAF: EPIDEMIOLOGY AND A SKI CLINIC
Anna Sans, Hospital Sant Joan de Déu D' Esplugues. Barcelona, España.
www.cipd2015.com
Pág. 14
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
NEUROPSYCHOLOGY AND LEARNING IN THE EAF
Natália Picó, Fundació Institut de Psicologia. Barcelona, España.
PSYCHIATRIC COMORBIDITY IN THE EAF
Núria Gómez, Hospital Universitari Vall d´Hebron. Barcelona, España.
14:00 – 15:30
Room 7
Track: Alcohol
Symposium - SY17
ALCOHOL AND AGRESSION: AN INTIMATE RELATIONSHIP!
Chair:
Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal.
Speakers:
ALCOHOL AND SEXUAL ASSAULT
Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal.
ALCOHOL AND AGRESSION - VICTIMS AND THE SNOWBALL EFFECT
Tânia Abreu, Centro Hospitalar Tamega E Sousa. Penafiel, Portugal.
ALCOHOL, SEVERE MENTAL ILLNESS AND AGRESSION
Catarina Freitas, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal.
ALCOHOL, ANTISOCIAL PERSONALITY AND AGRESSION
Teresa Sousa-Ferreira, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal.
14:00 – 15:30
Room 8
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Debate Forum - DF06
EFFECTIVENESS OF PSYCHOLOGICAL TREATMENTS IN DUAL PATHOLOGY AND ADEQUACY
OF RESOURCES. HAVE WE CHANGED ONE ADDICTION FOR ANOTHER?
Chair:
Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España.
Speakers:
PSYCHOLOGICAL INTERVENTION IN DUAL PATHOLOGY: AN INTEGRATED NETWORK MODEL
OF SOCIAL AND HEALTH RESOURCES IN THE CITY OF BARCELONA
Cristo M. Cruz, Centre d'Atenció i Seguiment Sarrià. Barcelona, España.
TREATMENT, EFFICACY AND THE FIGURE OF THE PSYCHOTHERAPIST
Mª Elena Bernal, Servicio Provincial de Drogodependencias de la Diputación de Almería,
España.
PSYCHOTHERAPIES IN DUAL PATHOLOGY
Diana Kushner, Universidad de Santiago de Chile. Santiago, Chile.
EVOLUTION OF TREATMENT PROGRAMS IN DUAL PATHOLOGY
Abel Baquero, PPDG Consorcio Hospitalario Provincial de Castellón. Comunidad Valenciana,
España.
14:00 – 15:30
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
14:00 – 15:30
Room 10
Track: Transcultural
Psychiatry
Symposium - SY18
IDENTIFYING STRATEGIES FOR IMPROVING CARE FOR LATINO IMMIGRANTS WITH DUAL
DISORDERS IN SPAIN AND THE U.S.: RESULTS FROM THE INTERNATIONAL LATINO
RESEARCH PARTNERSHIP
Chair:
www.cipd2015.com
Pág. 15
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Margarita Alegria, Harvard Medical School, Somerville. MA, USA.
Speakers:
COMPARISON OF MENTAL HEALTH TREATMENT EXPENDITURES AMONG PATIENTS WITH
DUAL DISORDERS IN USUAL PSYCHIATRIC CARE BETWEEN MADRID AND BOSTON HOSPITAL
SYSTEMS
Rodrigo Carmona, Fundación Jiménez Diaz. Madrid, España.
AN INTERNATIONAL COMPARISON OF EPISODES OF SUBSTANCE ABUSE TREATMENT
AMONG NATIVE-BORN AND LATINO IMMIGRANTS IN PUBLIC HOSPITAL SETTINGS IN
BARCELONA AND BOSTON
Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España.
COMMONALITIES AND DIFFERENCES IN BEHAVIORAL HEALTH CARE FOR LATINO
POPULATIONS IN PRIMARY CARE
Daniel Gonzalez, Cambridge Health Alliance, Somerville. MA, USA.
THE TESTING OF THE AC-OK WITH AN INTERNATIONAL SAMPLE OF LATINO IMMIGRANTS
Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico.
14:00 – 14:45
Room 11
Track: Child &
Adolescent Psychiatry
Workshop - WS04
ADDICTIONS AND DUAL DISORDERS IN JUVENILE JUSTICE
Chair:
Rosa de Sta. Mª Pérez, Parc Sanitari Sant Joan de Deu. Barcelona, España.
Speakers:
MENTAL HEALTH CARE AND SUBSTANCE ABUSE IN YOUNG OFFENDERS: AN INTEGRATIVE
APPROACH TO HEALTH CARE IN THE FIELD OF JUVENILE JUSTICE IN SPAIN
Jorge M. Garcia, Hospital Punta de Europa de Algeciras. Cádiz, España.
VULNERABILITY AND DUAL PATHOLOGY IN YOUNG OFFENDERS
Jaume Martinez, Unitat Terapéutica de Justica Juvenil Els Til·lers. Barcelona, España.
SPECIFICS OF THE MANAGEMENT AND TREATMENT OF DUAL PATHOLOGY IN TEENAGERS
WITH MANY PROBLEMATIC QUESTIONS
Jaume Claramunt, Parc Sanitari Sant Joan de Deu. Barcelona, España.
14:45 – 15:30
Room 11
Track: Personality
Disorders
Workshop - WS05
ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE
PERSONALITY DISORDER
Chair:
Maite Utges, Hospital Santa Maria. Lleida, España.
Speakers:
THE ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND
BORDERLINE PERSONALITY DISORDER, A DANGEROUS COMBINATION
Maite Utges, Hospital Santa Maria. Lleida, España.
APPROPRIATE USE OF INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS) IN THE
TREATMENT OF BORDERLINE PERSONALITY DISORDER (BPD)
Enrique Díaz, Hospital de Santa María, Lleida, España.
14:00 – 15:30
Oral Communications - OC03
www.cipd2015.com
Pág. 16
Saturday April 18th
Room 12
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Chairs:
José M. Goikolea, Hospital Clinic, Barcelona, España.
Pier P. Pani, Social-Health Services, Health District 8, Cagliari, Italy.
FORENSIC PSYCHIATRIC SERVICES IN THE ARAB WORLD, THE PAST AND THE FUTURE
1
2
3
Hasanen Al-Taiar , Saif Al-Hashimi , Moustafa Hussien Soltan
1
Oxford Health NHS Foundation Trust, United Kingdom.
2
Armed Forces Hospital. Muscat, Oman.
3
Egypt.
ABUSE OF VIDEO GAMES AND THE INTERNET IN A CASE OF AUTISM
R. Cappai, S. Marras, I. Obbili
Studio di Psicologia, Costruttivamente. Cagliari, Italy.
AN EXPLORATORY ONLINE SURVEY ON THE PREVALENCE OF HYPERSEXUAL BEHAVIOUR
R. Gupta, D. Deka, YPS. Balhara
All India Institute of Medical Sciences, New Delhi, India.
LIMES, LIMEN. BORDERLINE PERSONALITY DISORDER AND SUBSTANCES ABUSE: TWO
LINKED PATHOLOGIES ON THE BORDER BETWEEN NEUROLOGY AND PSYCHIATRY, LAW
AND CLINIC
Marco Mollica, Veronica Aiello
DINOGMI, Section of Psychiatry, University of Genoa, San Martino Hospital, Largo Rosanna
Benzi 1, Genoa, Liguria, Italy.
FEATURES AND PERMANENCE IN TREATMENT OF A SAMPLE OF DRUG USERS LEGALLY
CONDITIONED TO TAKE TREATMENT IN CENTERS OF YOUTH INTEGRATION TLALPAN
1
2
C. Tejeda Romero , DB Díaz Negrete
1
Centros de Integración, Tlalpan, DF, México.
2
Centros de Integración Juvenil, DF, México.
BUILDING AN INDIVIDUALIZED PROFILE FOR TREATMENT ACROSS BEHAVIORAL
ADDICTIONS
1.2
N. el-Guebaly
1
University of Calgary, Alberta, Canada.
2
Alberta Gambling Research Institute, Alberta, Canada.
NURSING INTERVENTION IN DRUG ADDICTION CENTERS (CAD) PROTOCOL
1
2
3
4
S. Gutiérrez Cáceres , J. Chicharro Romero , M. Sáez García , D. Coca Pérez , J. Martín
5
6
6
5
7
Herrero , N. García Hidalgo , N. Salgado Marcos , C. López Jiménez , A. Vicente Partido , C.
5
Culebras García
1
DUE CAD Latina, Madrid, España.
2
DUE CAD San Blas, Madrid, España.
3
DUE CAD Hortaleza, Madrid, España.
4
DUE CAD Tetuan, Madrid, España.
www.cipd2015.com
Pág. 17
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
5
DUE CAD Arganzuela, Madrid, España.
DUE CAD Vallecas, Madrid, España.
7
DUE CAD Villaverde, Madrid, España.
6
15:30 – 17:00 h.
15:30 – 17:00
Room 1
Track: Psychosis
Symposium – SY19
ARE THERE CLINICAL-NEUROBIOLOGICAL DIFFERENCES BETWEEN CANNABIS USERS WITH
PSYCHOSIS AND NON-USERS WITH PSYCHOSIS?
Chair:
Francisco Arias, Hospital Doce de Octubre. Madrid, España.
Speakers:
GENETIC VULNERABILITY TO PSYCHOSIS IN CANNABIS USERS AND NON-USERS
Francisco Arias, Hospital Doce de Octubre. Madrid, España.
CLINICAL AND PREPULSE INHIBITION DEFICIT DIFFERENCES BETWEEN CANNABIS-INDUCED
PSYCHOTIC DISORDER AND SCHIZOPHRENIA
Gabriel Rubio, Universidad Complutense de Madrid. Madrid, España.
DIFFERENCES IN TREATMENT AND EVOLUTION BETWEEN CANNABIS USERS AND NONUSERS AFTER STARTING THE FIRST PSYCHOTIC EPISODE PROGRAMME CARRIED OUT AT
THE 12TH OCTOBER HOSPITAL, MADRID.
Isabel Martínez, Hospital Doce de Octubre. Madrid, España.
15:30 – 17:00
Room 2-3
Track: Cannabis and
Dual Disorders
Debate Forum - DF07
CANNABIS: NEW INTERNATIONAL REGULATION. WHAT IS THE RISK IN DUAL DISORDERS?
Chair:
Manuel Mas-Bagá, CAT Barcelona, España.
Speakers:
NEW POLITICS ABOUT CANNABIS: AN OPORTUNITY IN PUBLIC HEALTH?
Joan Colom, Agència de Salut Pública de Catalunya, BarcOC01elona, España.
CANNABIS USE IN THE USA
Ruben Baler, National Institute on Drug Abuse. MD, USA.
LEGALIZATION OF THE USE OF CANNABIS
Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay.
15:30 – 17:00
Room 4
Track: Training Dual
Diagnosis
Invited Symposium – IS06
WHERE ARE DUAL DISORDERS IN DSM5?
Chair:
Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat
Autònom, Barcelona, España.
Speakers:
SUBSTANCE-RELATED AND ADDICTIVE DISORDERS IN DSM-5: WHAT'S NEW?
Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France.
DUAL DISORDERS IN DSM-5: AN OVERVIEW
Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA.
SOME EXAMPLES OF COMORBIDITY WITH SUD IN DSM-5
www.cipd2015.com
Pág. 18
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA.
15:30 – 17:00
Room 5
Track: Penitentiary
(Prisons) & Dual
Pathology
Symposium - SY20
REHAB PROJECT AND OTHER DUAL DISORDERS APPROACHES IN EUROPEAN PRISONS
Chair:
Fabio Sternberg, Federación Europea de Sanidad Penitenciaria. Barcelona, España.
Speakers:
DUAL DISORDERS APPROACH IN SPANISH PRISONS
José M. Antolín, Sociedad Española de Sanidad Penitenciaria (SESP). Barcelona, España.
DUAL DISORDERS APPROACH IN FRENCH PRISONS
Fadi Meroueh, Asociación de Profesionales Sanitarios en Prisión (APSEP), Francia.
Cyril Manzanares, Servicios Médicos de la Prisión Villeneuve Les Maguelone - CHU
Montpellier, France.
REHAB PROJECT AS AN APPROACH IN DUAL DISORDERS IN PRISON. THE VITERBO-ITALY
EXPERIENCE
Roberto Monarca, Sociedad Italiana de Medicina y Sanidad Penitenciaria (SIMSPe), Italy.
15:30 – 17:00
Room 6
Track: Evaluation
processes in Dual
Disorders
Symposium - SY21
OUTCOME MEASURES IN HEROIN ADDICTED PATIENTS WITH DUAL DISORDERS TREATED
WITH OPIOID AGONIST MEDICATIONS
Chair:
Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital,
Pisa, Italy.
Speakers:
INCREASING IMPORTANCE OF MEASURING OUTCOMES IN OPIOID DEPENDENCE CARE
Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital,
Pisa, Italy.
STUDYING PSYCHOPATHOLOGY OF HEROIN ADDICTS AS OUTCOME MEASURES
Pier P. Pani, Social-Health Services, Health District 8 (ASL 8) Cagliari, Italy.
QUALITY OF LIFE AND CRAVING BEHAVIOUR AS OUTCOME MEASURES IN HEROIN ADDICTS
Angelo G.I. Maremmani, University of Pisa. Pisa, Italy.
15:30 – 17:00
Room 7
Track: Alcohol
Symposium - SY22
ALCOHOL CONSUMPTION DURING ADOLESCENCE AS A VULNERABILITY FACTOR IN DUAL
DISORDERS
Chair:
Olga Valverde, Universitat Pompeu Fabra. Barcelona, España.
Speakers:
DELETERIOUS EFFECTS OF ALCOHOL CONSUMPTION DURING CRITICAL PERIODS OF LIFE
Olga Valverde, Universitat Pompeu Fabra. Barcelona, España.
ETHANOL, STRESS AND ADOLESCENCE
Marta Rodríguez-Árias, Universidad de Valencia. Comunidad Valenciana, España.
NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY MATERNAL SEPARATION AND
VULNERABILITY TO ALCOHOL CONSUMPTION IN MICE
Jorge Manzanares, Universidad Miguel Hernández. Alicante, España.
ADDICTION RESEARCH AND HUMAN PHARMACOLOGY GROUPS, NEUROSCIENCES
RESEARCH PROGRAM, IMIM
Francina Fonseca, Hospital del Mar. Barcelona, España.
15:30 – 17:00
Room 8
Debate Forum - DF08
MULTIDISCIPLINARITY IN DUAL PATHOLOGY AND ITS KEYS: PSYCHOLOGICAL
www.cipd2015.com
Pág. 19
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Track:
Psychotherapeutic
Treatment in Dual
Disorders
INTERVENTION
Chair:
José A. Carrobles, Universidad Autónoma de Madrid, España.
Speakers:
TRANSDIAGNOSIS AND DUAL PATHOLOGY
José A. Carrobles, Universidad Autónoma de Madrid, España.
ROLE OF THE PSYCHOLOGIST: THE NEED TO INTEGRATE THE DISCIPLINE IN DUAL
PATHOLOGY
Mª Nieves Gómez, Ayuntamiento San Sebastian de Los Reyes, Madrid, España.
THE ROLE OF THE PSYCHOLOGIST IN DUAL PATHOLOGY IN AN INTERDISCIPLINARY
ADDICTIONS CARE TEAM
Marcela Coromina, Centre d'Atenció i Seguiment Sarrià, Centre d'Atenció i Seguiment
Baluard. Barcelona, España.
15:30 – 17:00
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
15:30 – 17:00
Room 10
Track: Attention Deficit
Symposium – SY23
ADDICTIVE DISORDERS IN ADHD PATIENTS: A SELF-MEDICATION PROBLEM?
Chair:
Jorge Jaber, Clínica Jorge Jaber. Rio de Janeiro, Brasil.
Speakers:
ADDICTIVE DISORDERS IN ADHA PATIENTS
José Temótio, Unidade Patologia Dual. C.H.U. Coimbra, Portugal.
NEUROBIOLOGY OF ADHA AND ADDICTIVE DISORDERS
Eugenio H. Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical
Hospital. Porto Alegre, Brasil.
SELF-MEDICATION HYPOTHESIS IN ADDICTIVE DISORDERS IN ADHA PATIENTS
Célia Franco, Unidade Patologia Dual. C.H.U. Coimbra, Portugal.
15:30 – 16:15
Room 11
Track: Transcultural
Psychiatry
Workshop - WS06
BETWEEN EAST AND WEST: CHALLENGES IN TREATMENT OF PATIENTS WITH DUAL
DISORDERS
Chair:
Andrej Kastelic, Center for Treatment of Drug Addiction, University Psychiatric Hospital
Ljubljana, Slovenia.
Speakers:
ARE THEY (WE) DIFFERENT?
Nusa Segrec, Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana,
Slovenia.
BREAKING BARRIERS FOR TREATMENT OF DRUG USERS WITH DUAL DIAGNOSES WITH AIM
TO IMPROVE THE ACCESS AND QUALITY OF TREATMENT
Ljiljana Ignjatova, Psychiatric Hospital Skopje. Skopje, Macedonia.
HOW STIGMA WILL DELAY A TREATMENT
Luis Patricio, Casa de Saude De Carnaxide. Carnaixade, Portugal.
www.cipd2015.com
Pág. 20
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
TREATING PEOPLE WITH MENTAL HEALTH PROBLEMS AND ADDICTION IN CLOSED
SETTINGS
Andrej Kastelic, Center for Treatment Of Drug Addiction, University Psychiatric Hospital
Ljubljana, Slovenia.
16:15 - 17:00
Room 11
Track: Gender and
Dual Diagnosis
Workshop - WS07
TREATMENT OF CHALLENGING BEHAVIOURS IN HIGH FUNCTIONING WOMEN WITH
AUTISM SPECTRUM DISORDER AND DUAL DISORDER
Chair:
Patricia J.M. van Wijngaarden-Cremers, Dimence Mental Health. Deventer, The Netherlands.
Speakers:
Patricia J.M. van Wijngaarden-Cremers, Dimence Mental Health. Deventer, The Netherlands.
Rutger Jan van der Gaag, Radboud University Medical Centre, Royal Dutch Medical
Association. Utrecht, The Netherlands.
15:30 – 17:00
Room 12
Oral Communications - OC04
Chairs:
Carmen Barral, Hospital Universitari Vall d'Hebron. Barcelona, España.
Edgard Belfort, Hospital Psiquiátrico de Venezuela, Caracas, Venezuela.
FAMILY HISTORY OF SUBSTANCE ABUSE AND ITS IMPACT ON PSYCHOSOCIAL SKILLS
PROGRAMS TO PREVENT SCHOOL VIOLENCE IN TEGUCIGALPA, HONDURAS
Edwing Octavio Garcia Toro
Facultad de Ciencias Médicas Universidad Nacional Autónoma de Honduras. Honduras.
TAKING THE PLUNGE- A QUALITATIVE STUDY OF HOPE WITHIN THE MENTAL HEALTH AND
SUBSTANCE ABUSE SERVICES
Knut Tore Sælør, Ottar Ness, Randi Semb
Buskerud and Vestfold University College, Drammen, Norway.
COMPARATIVE STUDY OF UNIVERSITY STUDENTS, SONS OF ALCOHOLICS IN PUERTO RICO
AND COSTA RICA
J. Serra, A. Villafañe, M. Jiménez, W. Jiménez
Universidad de Puerto Rico, San Juan, Puerto Rico.
SEX ADDICTION : PSYCHIATRIC AND PSYCHOTHERAPEUTIC PERSPECTIVES
Feldman Nelson, Sophia Ahab, Rodolphe Soulignac, Yasser Khazaal, Daniele Zullino
Service d’Addictologie, Département de santé mentale et psychiatrie, University Hospital of
Geneva HUG, Switzerland.
COCAINE IMPAIRS CELL GENESIS DURING ADOLESCENCE: IMPLICATIONS FOR DEPRESSIONLIKE BEHAVIOR IN ADULTHOOD
M.J. García-Fuster, R. García-Cabrerizo, B. Keller
University of the Balearic Islands, Palma de Mallorca, España.
www.cipd2015.com
Pág. 21
Saturday April 18th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
QUALITY OF LIFE OF MEN WITH ALCOHOL DEPENDENCE SYNDROME
1, 2
2
I. Linnuste , K. Lang
1
Foundation Pärnu Hospital, Pärnu, Estonia.
2
University of Tartu, Tartu, Estonia.
THE ROLE OF FAITH, SPIRITUALITY AND RELIGION IN THE PROCESS OF RECOVERY FROM
DUAL DISORDERS
Susana E. Mendez
Enterhealth, Residential and Outpatient Services. Dallas, TE, USA.
IMPLEMENTATION OF AN INTEGRATED CARE PATHWAY FOR CONCURRENT MAJOR
DEPRESSIVE DISORDER AND ALCOHOL DEPENDENCE
1,2
1
1
1,2
1,2
A.V.Samokhvalov , J.A.Irving , S.Awan , B. Le Foll , P.Voore
1
Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
2
University of Toronto, Toronto, Ontario, Canada.
THE PREVALENCE OF MENTAL DISORDERS AMONG LESBIAN, GAY, BISEXUAL AND
TRANSGENDER (LGBT) IN BAGHDAD
Aziz Salim Shakir Fibms
Iraqi Ministry of Health, Iraq.
17:00 - 19:00 h.
17:00 – 17:30
Auditorium
OPENING CEREMONY
17:30 – 19:00
Auditorium
Track: Multidisciplinary
Intervention in Dual
Disorders
Plenary Session - PS02
BRAIN ADDICTIVE CIRCUITS ARE COMMON TO OTHER MENTAL ILLNESSES
Chair:
Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio
Marañón. Madrid, España.
Speaker:
Nora Volkow, National Institute on Drug Abuse (NIDA), Bethesda. MD, USA.
NETWORKING EVENING
19:00 – 20:30
Auditorium
www.cipd2015.com
Pág. 22
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
08:30 – 10:00 h.
08:30 – 10:00
Auditorium A
Track: Attention Deficit
Symposium – SY24
DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN DUAL ADHD
Chair:
Salvador Ros, Hospital del Mar. Universidad Autónoma de Barcelona, España.
Speakers:
ADHD AND SUBSTANCE USE DISORDER
Juan Ramirez, Servicio Provincial Drogodependencias y Adicciones Huelva. España.
ADHD AND BEHAVIORAL ADDICTIONS
Juncal Sevilla, Universidad Autónoma de Madrid, Fundación Jimenez Díaz. Madrid, España.
NEW CHALLENGES IN TREATMENT OF DUAL ADHD
Andres Fontalba, Centro Salud Mental de Distrito, Huercal-Olvera. Huelva, España.
08:30 – 09:15
Room 1
Track: Opioid System
and Dual Disorders
Main Lecture - ML06
ROLE OF KAPPA OPIOID RECEPTORS IN THE TREATMENT OF DUAL PATHOLOGY
Chair:
Julio Bobes, Universidad de Oviedo, España.
Speaker:
Iván Montoya, Division of Pharmacotherapies and Medical Consequences of Drug Abuse,
NIDA, USA.
09:15 – 10:00
Room 1
Track: Attention Deficit
Main Lecture - ML07
REVISTING OLD CONCEPTS ON ADULT ADHD
Chair:
Luis Alfonzo B., Organización Panamericana de la salud. Washington, USA.
Speaker:
Luis A. Rohde, Federal University of Rio Grando do Sul, Department of Psychiatry, Porto
Alegre, Brasil.
08:30 – 10:00
Room 2-3
Track: Spirituality and
Dual Disorders
Symposium - SY25
DUAL DISORDERS AND FREE WILL
Chair:
Célia Franco, Centro Hospitalar Universitário de Coimbra, Portugal.
Speakers:
DUAL DISORDERS AND FREE WILL. WHAT IS HAPPENING?
Luiz C. Coronel, Centro de Estudios Jose de Barros Falcão. Porto Alegre, Brasil.
DUAL PATHOLOGY AND MENTAL COMPETENCES, WHAT CHANGES?
Alfredo Calcedo, Universidad Complutense de Madrid. Madrid, España.
08:30 – 10:00
Room 4
Track: Cannabis and
Dual Disorders
Symposium - SY26
POTENTIAL THERAPEUTIC USE OF CANNABINOID RECEPTORS AND PHYTOCANNABINOIDS
IN DUAL PATHOLOGY
Chair:
www.cipd2015.com
Pág. 23
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Jorge Manzanares, Universidad Miguel Hernández. Alicante, España.
Speakers:
THERAPEUTIC PERSPECTIVES OF CANNABIDIOL (CBD) IN THE TREATMENT OF
NEUROPSYCHIATRIC DISORDERS
Jorge Manzanares, Universidad Miguel Hernández. Alicante, España.
RELEVANCE OF THE REGULATION OF CANNABINOID SYSTEM IN DUAL PATHOLOGY
Mª Salud García, Instituto de Neurociencias, Universidad Miguel Hernández. Alicante,
España.
ROLE OF CANNABINOID CB1 RECEPTOR IN DRUG ADDICTION AND DUAL PATHOLOGY
Olga Valverde, Universitat Pompeu Fabra. Barcelona, España.
08:30 – 10:00
Room 5
Track: Opioid System
and Dual Disorders
Symposium - SY27
RESPONSE PREDICTION IN HEROIN-ASSISTED TREATMENT: THE ROLE OF DUAL DISORDERS
Chair:
Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The
Netherlands.
Speakers:
COMORBID COCAINE DEPENDENCE IN HEROINE-ASSISTED TREATMENT: PREDICTING
OUTCOME A TREATING POLYDRUG ADDICTION
Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The
Netherlands.
OUTCOMES FOR PSYCHIATRIC COMORBIDITY IN HEROIN ASSISTED TREATMENT:
PREDICTIVE FACTORS
Teodora Groshkova, Centre for Health Evaluation & Outcome Sciences, Providence Health
Care, Canada.
RESPONSE TO INJECTABLE OPIOID TREATMENT IN PARTICIPANTS WITH MODERATE VS.
LOW PSYCHOPATHOLOGY SYMPTOMS
David C. Marsh, Northern Ontario School of Medicine, Canada.
08:30 – 10:00
Room 6
Debate Forum - DF09
WADD
By invitation only
Chair:
Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine –
University of Miami. FL, USA.
Co-chairs:
Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron.
Barcelona, España.
Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio
Marañón. Madrid, España.
08:30 – 10:00
Room 7
Track:
Psychoestimulants
Invited Symposium – IS07
THE OLD COUPLE: COCAINE AND PSYCHOSIS
Chair:
Carlos Roncero, Universidad Autónoma de Barcelona, España.
www.cipd2015.com
Pág. 24
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Speakers:
GENETIC FEATURES OF COCAINE INDUCED PSYCHOSIS
Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment
Research Center. PA, USA.
EPIDEMIOLOGY OF COCAINE INDUCED PSYCHOSIS
Florence Vorspan, Publique-Hôpitaux de Paris, France.
PSYCHOPATHOLOGICAL DIFFERENCES BETWEEN COCAINE-INDUCED PSYCHOSIS AND
INDEPENDENT PSYCHOSIS IN COCAINE USERS
Francisco González-Saiz, Unidad de Salud Mental Comunitaria, Hospital de Jerez, España.
08:30 – 10:00
Room 8
Track: Behavioral
addictions / Gambling
Disorders
Symposium – SY28
EMOTIONAL DEPENDENCE: A NEW ADDICTION WITHIN THE FRAMEWORK OF DUAL
DISORDERS?
Chair:
Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España.
Speakers:
EMOTIONAL DEPENDENCE VERSUS LOVE ADDICTION
Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia,
España.
GENDER VIOLENCE AND EMOTIONAL DEPENDENCY
Leticia Camarillo, Hospital General Universitario Gregorio Marañón. Madrid, España.
08:30 – 10:00
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
08:30 – 10:00
Room 10
Track: Planning,
regulations and
resource management
Symposium – SY29
ORGANIZATION AND RESOURCES FOR DUAL DISORDERS ASSISTANCE
Chair:
Luis Caballero, Hospital Universitario Puerta de Hierro. Madrid, España.
Speakers:
ORGANIZATION AND RESOURCES FOR DUAL DIAGNOSIS UNIT IN A MENTAL HOSPITAL IN
LATIN AMERICA IN THE LAST CENTURY
Elvia Velásquez, Alad (Latinoamerican Association On Addiction), Colombia.
RESOURCES AND ORGANIZATION FOR DUAL PATHOLOGY ASSISTANCE IN ITALY
Massimo Clerici, Universidad di Milano. Milano, Italy.
08:30 – 10:00
Room 11
Track: Impulsivity
Invited Symposium - IS08
IMPULSIVITY: A KEY SYMPTOM OR A KEY TREAT IN DUAL DISORDERS?
Chair:
Rodrigo Cordoba, Grupo CISNE, Bogotá, Colombia.
Speakers:
DUAL PATHOLOGY AND COMPULSIVE IN-TAKES
Gabriel Rubio, Universidad Complutense de Madrid, España.
INFLUENCE OF IMPULSIVITY IN SUICIDE ATTEMPTS, DRIVING ACCIDENTS AND SEVERITY OF
ADDICTIONS
www.cipd2015.com
Pág. 25
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Laia Rodríguez-Cintas, CAS Vall d'Hebron, Hospital Universitari Vall d'Hebron. Barcelona,
España.
INFLUENCE OF IMPULSIVITY IN DUAL ADHD
Eugenio Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical
Hospital. Porto Alegre, Brasil.
08:30 – 10:00
Room 12
Oral Communications - OC05
Chairs:
Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España.
Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland.
LOW-DEMAND TREATMENT IN DUAL DISORDERS
1
1,2
1,3
1
R. Fernández López , P. Sanz Asín , A. Bruguera Guitart , D. Aránega Guizán , M.
1,3
1
1
1
Coromina Gimferrer , S. Martí Climent , G. López Cano , M.T. Bello Mayoraz
1
CAS Baluard, Barcelona, España.
2
CAS Sants, Barcelona, España.
3
CAS Sarrià, Barcelona, España.
ABORDAJE Y MANEJO DE LA DINÁMICA FAMILIAR EN LA PATOLOGÍA DUAL
1
2
3
Lucas García Thuring , Mª Nieves Gómez Llano , Soledad Marzo Pons
1
CTD El ALba. JCCM. España.
2
Ayuntamiento San Sebastian de los Reyes. Madrid, España.
3
Ayuntamiento de Madrid. España.
THE EFFECT OF PRESCRIBING METHADONE ON CHANGING OF MOODS IN OPIUM ADDICTS
1
2
3,
Alireza Homayouni , Seyed Jalal Mosavi Amiri , Arsalan KhanmohammadiOtaghsara
4
Gholamali Nikpour
1
College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran.
2
Medical Clinic of Dr. Mosavi, Amirkola, Iran.
3
College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran.
4
Allameh Tabatabaii University, Tehran, Iran.
ADDICTION, TRAUMA, MENTAL ILLNESS- TREATMENT OPTIONS FOR COMPLEX
CONCURRENT DISORDERS
Reinhard Michael Krausz
University of British Columbia (UBC). NY, USA.
MULTIDISCIPLINARY RESIDENTIAL INTERVENTION IN DUAL DISORDER
E. Muscas, G. Trincas, P. Pili, G. Sanna, G. Grillo
Casa Emmaus, Iglesias, Italia.
A TRANSDIAGNOSTIC THERAPY FOR BEHAVIORAL DYSREGULATION: MINDFULNESS AND
MODIFICATION THERAPY CUSTOMIZED FOR ALCOHOL USE, DRUG USE, AND ANGER ISSUES
1,2
1
1
1
1
1
1
P. Wupperman , A.L. Reed , E. Edwards , R. Shapiro , Q. Li , F. Unachukwa , B. Ryan
1
John Jay College/City University of New York, New York, New York, USA.
www.cipd2015.com
Pág. 26
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
2
Yale University Medical Center, New Haven, Connecticut, USA.
A DRUG TREATMENT PROGRAM FOR YOUNG ISRAELI BACKPACKERS WHO SUFFER FROM
DUAL DIAGNOSIS
1
2
Hagit Bonny-Noach , Haim Mell
1
Ariel University & Beit Berl Academic College- Israel. Consultant, Israel Anti- Drug Authority
(IADA). Board Member- Israeli society of Addiction Medicine(ILSAM), Israel.
2
Head, Treatment & Rehabilitation Division, Israel Anti-Drug Authority, Israel.
HOSPITALISATION OF SERVICE USERS BEFORE AND AFTER ADMISSION TO ASSERTIVE
COMMUNITY TREATMENT IN NORWAY – DOES SUBSTANCE USE MATTER?
1
1
1
2
2
2
H. Clausen , T. Ruud , K.S. Heiervang , S. Odden , H.K. Stuen , A. Landheim
1
Akershus University Hospital, Lørenskog, Norway.
2
National Centre for Dual Diagnosis, Innlandet Hospital Trust, Hamar, Norway.
NALMEFENE IN ALCOHOL USE DISORDER: A PRELIMINARY STUDY
1
2
3
L.A. Núñez Domínguez , M García Nicolás , O Arbeo Ruiz
1
Centro Médico, Pamplona, Navarra, España.
2
Mental Health Center, Tudela, Navarra, España.
3
Centro de Día Zuría, Pamplona, Navarra, España.
10:00 – 12:00 h.
10:00 – 12:00
Room 1
SATELLITE Symposium
Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00
Room 2-3
SATELLITE Symposium
Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00
Room 6
SATELLITE Symposium
Industry Session not included in official scientific programme CME/CPD
12:00 – 15:00 h.
12:00 – 13:30
Auditorium A
Track: Multidisciplinary
Intervention in Dual
Disorders
www.cipd2015.com
Symposium – SY30
MULTIMODAL APPROACHES FOR ADHD AND DUAL DISORDERS
Chair:
Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM.
Valencia, España.
Speakers:
NON-PHARMACOLOGICAL INTERVENTIONS IN CHILDREN AND ADOLESCENTS WITH ADHD
Maite Ferrin, The Huntercombe Hospital Maidenhead, Institute of Psychiatry London. London,
Pág. 27
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
United Kingdom.
THE EFFICACY AND LIMITATIONS OF PHARMACOLOGICAL MANAGEMENT OF ADULT ADHD
AND DUAL DISORDERS
Eugenio H. Grevet, Federal University of Rio Grande Do Sul (UFRGS). Porto Alegre Clinical
Hospital. Porto Alegre, Brasil.
THE EXPANDING ROLE OF NUTRITIONAL PSYCHIATRY AND LIFESTYLE MEDICINE FOR
BIPOLAR DISORDERS
Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM.
Valencia, España.
INTEGRATED BIOPSYCHOSOCIAL-SPIRITUAL TREATMENT FOR ADDICTIONS AND COOCCURRING DISORDERS
Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA.
12:00 – 12:45
Room 1
Track: Multidisciplinary
Intervention in Dual
Disorders
Main Lecture - ML08
DUAL DISORDERS AND MENTAL DISORDERS
Chair:
Carmen Leal, Facultad De Medicina De Valencia. Comunitat Valenciana, España.
Speaker:
Julio Sanjuan, Universitat de Valencia. Comunitat Valenciana, España.
12:45 – 13:30
Room 1
Track: Personality
Disorders
Main Lecture - ML09
UPDATE: PSYCHOPATHY IN DUAL PATHOLOGY
Chair:
Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron.
Barcelona, España.
Speaker:
Rafael Torrubia, Universidad Autónoma de Barcelona. Barcelona, España.
12:00 – 14:00
Room 2-3
Debate Forum – DF10
WPA SECTION ON DUAL DISORDERS
By invitation only
Chair:
Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine –
University of Miami. FL, USA.
Co-chairs:
Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio
Marañón. Madrid, España.
Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina.
Nady El-Guebaly, University of Calgary. Alberta, Canada.
12:00 – 13:30
Room 4
Track: Cannabis and
Dual Disorders
Symposium – SY31
RESEARCH IN NEUROBIOLOGY AND CLINICAL TRIALS REGARDING DISORDERS DUE TO
CANNABIS ABUSE AND IN PSYCHOEDUCATIONAL GROUP THERAPY FOR PATIENT’S
FAMILIES
Chair:
www.cipd2015.com
Pág. 28
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Josep Solé, Centre D'Atenció I Seguiment De Drogodependències Benito Menni. Barcelona,
España.
Speakers:
NEUROPSYCHOLOGICAL DISORDERS ASSOCIATED WITH CANNABIS USE
Laura Blanco, Centre D'Atenció I Seguiment De Drogodependències Benito Menni. Barcelona,
España.
DATA FROM CLINICAL RESEARCH CANNABIS ADDICTION
Begoña Gonzalvo, Centre D'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM.
Barcelona, España.
PSYCHOEDUCATIONAL GROUP THERAPY AIMED AT FAMILY MEMBERS OF PEOPLE WITH
SUBSTANCE DEPENDENCE DISORDER LINKED TO A DRUG ADDICTION CENTER
Alfredo Felices de la Fuente, Centre D'Atenció I Seguiment Sant Boi Llobregat. Benito Menni
CASM. Barcelona, España.
12:00 – 13:30
Room 5
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium - SY32
NEW PSYCHOACTIVE DRUGS: APPROACH, PERSPECTIVES AND PSYCHOPATHOLOGY
Chair:
Helen Dolengevich, Hospital Universitario Del Henares. Madrid, España.
Speakers:
MEDICAL APPROACH TO THE INTOXICATED PATIENT. WHAT NEEDS TO CHANGE?
Daniel Sánchez, Hospital Universitario La Fe. Valencia, España.
NEWEST PSYCHOACTIVE DRUGS ON THE NET
Jorge Gómez-Arnau, Hospital Universitario Del Henares. Madrid, España.
SYNTHETIC CANNABINOIDS AND PSYCHOPATHOLOGY: PSYCHOSIS IN THE SPOTLIGHT
Carlos Parro, C.S. Mental Retiro. Hospital Universitario Gregorio Marañón. Madrid, España.
12:00 – 13:30
Room 6
Track: Epidemiology
and Dual Disorders
Invited Symposium – IS09
EPIDEMIOLOGY
Chair:
Josep Mª Haro, Hospital San Joan de Deu. Barcelona, España.
Speakers:
EPIDEMIOLOGY OF ALCOHOL CONSUMPTION IN DUAL PATIENTS
Teresa Brugal, Agencia de Salut Pública Barcelona. Barcelona, España.
GENDER DIFFERENCES IN PACIENTS WITH DUAL ALCOHOLISM
Jesús Perez Pazos, Centre d'Atenció I Seguiment de Drogodependències Vall d'Hebron.
Barcelona, España.
ALCOHOL CONSUMPTION IN ADOLESCENTS IN DUAL PATHOLOGY
Rodrigo Córdoba, Centro de Investigaciones del Sistema Nervioso (Grupo Cisne). Bogotá,
Colombia.
12:00 – 13:30
Room 7
Track: Child &
Adolescent Psychiatry
Symposium - SY33
ATTENTION TO ADOLESCENTS AND YOUNG ADULTS IN THE INSTITUTE OF ADDICTIONS
MADRID SALUD. CHALLENGE IN THE INTERVENTION OF DUAL PATHOLOGY
Chair:
www.cipd2015.com
Pág. 29
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Antonio Prieto, Madrid Salud (Salud Pública del Ayuntamiento de Madrid), España.
Speakers:
DOES THE PROCESS MANAGEMENT INCREASE THE QUALITY AND EFFICIENCY IN THE CARE
OF ADOLESCENTS WITH PROBLEMS OF ADDICTION?
Mª Teresa Pérez, Instituto de Adicciones de Madrid. Madrid, España.
INTERVENTION WITH ADOLESCENTS WITH DUAL DIAGNOSIS FROM A DEPENDENCE
ADDICTION CENTER
Marina Delgado, Instituto de Adicciones de Madrid. Madrid, España.
TREATMENT OF ADOLESCENTS AND YOUNG ADULTS IN A SPECIFIC THERAPEUTIC
RESOURCE
Pedro Pablo Herraiz, Instituto de Adicciones de Madrid. Madrid, España.
12:00 – 13:30
Room 8
Track: Psychosis
Symposium - SY34
PSYCHOSIS AND PSYCHOACTIVE SUBSTANCES: AN EVER CHANGING SCENARIO
Chair:
Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy.
Speakers:
COCAINE INDUCED PSYCHOTIC DISORDERS AND PSYCHOTIC SYMPTOMS IN COCAINE
DEPENDENT PATIENTS
Carlos Roncero, Universidad Autónoma de Barcelona, España.
THE LYSERGIC PSYCHOMA
Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy.
PSYCHOTIC EXPERIENCES AND SUBSTANCE ABUSE: THE CLUB SCENE IN IBIZA
Cristina Merino del Villar, Hospital Can Misses. Ibiza, España.
SYNTHETIC CANNABINOIDS AND "SPICEOPHRENIA"
Rita Santacroce, University "G.D'Annunzio", Chieti, Italy.
Duccio Papanti, University of Trieste, Trieste, Italy.
12:00 – 13:30
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
12:00 – 13:30
Room 10
Track: Planning,
regulations and
resource management
Symposium - SY35
DEVELOPMENT OF A NOVEL IN-PATIENT SERVICE MODEL AND PROGRAM FOR DUAL
DISORDERS
Chair:
Bridin Murnion, Sydney Local Health District. Sydney, Australia.
Speakers:
DEVELOPING A MODEL OF CARE FOR COMPLEX CO-MORBIDITY-A SYSTEMS PERSPECTIVE
Bridin Murnion, Sydney Local Health District. Sydney, Australia.
STAGE 3 CLIENTS PROGRAM
Danielle Florida, Concord Hospital. Concord, NSW, Australia.
STAGE 2 CLIENTS PROGRAM
Lisa Juckes, Concord Hospital. Concord, NSW, Australia.
DEVELOPING A MODEL OF CARE FOR COMPLEX CO-MORBIDITY-THE PATIENT AND STAFF
PERSPECTIVE
www.cipd2015.com
Pág. 30
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Wendy Kerley, Concord Hospital. Concord, NSW, Australia.
12:00 – 12:45
Room 11
Track: Evaluation
processes in Dual
Disorders
Workshop - WS08
ADOLESCENT TO PARENT VIOLENCE IN ADOPTED AND NON-ADOPTED TEENAGERS AND
YOUNG ADULTS WITH DUAL DISORDERS: A COMPARATIVE DIAGNOSTIC STUDY
Chair:
Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y
sus Familias. Barcelona, España.
Speakers:
DIAGNOSTIC CRITERIA FOR ADOLESCENT TO PARENT VIOLENCE IN ADOPTED AND NONADOPTED TEENAGERS AND YOUNG ADULT PATIENTS
Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y
sus Familias. Barcelona, España.
COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED TEENAGERS AND
YOUNG ADULTS WITH CHILD TO PARENT VIOLENT BEHAVIOUR
M. Àngels Feliu, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes
y sus Familias. Barcelona, España.
12:45 – 13:30
Room 11
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Workshop – WS09
MINDFULNESS FOR TREATING DUAL DISORDERS
Chair:
Rosa Tejedor, Centro de Atención Drogodependencias. Fundacion Althaia. Xarxa Assitencial
Universitaria de Manresa. Barcelona, España.
Speakers:
MINDFULNESS FOR TREATMENT TO SUBSTANCE USE DISORDERS
Rosa Tejedor, Centro de Atención Drogodependencias. Fundacion Althaia. Xarxa Assitencial
Universitaria de Manresa. Barcelona, España.
MINDFULNESS IN RELAPSE PREVENTION
Antonia Raich, Althaia Xarxa Assistencial Universitaria Manresa. Barcelona, España.
12:00 – 13:30
Room 12
Oral Communications - OC06
Chairs:
Enriqueta Ochoa, Hospital Ramón y Cajal de Madrid, España.
Luis Patricio, Casa de Saude de Carnaixade. Carnaixade, Portugal.
TRANSLATING EXPERIMENTAL FINDINGS INTO THE CLINICAL CONSULTING ROOM: A CASE
EXAMPLE
Cynthia Cabral
City College of New York, City University of New York, NY, USA. St. John’s University, Queens,
USA.
CANNABINOID HYPEREMESIS SYNDROM. A REPORT OF SIX NEW CASES AND A RESUME OF
PREVIOUS REPORTS
C. Contreras Narváez¹, M. Mola Gilbert², E. Batlle de Santiago², E. Giné Serven¹, J. Bigas
Farreres³
www.cipd2015.com
Pág. 31
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
1
Departamento de Salud Mental. Hospital de Mataró. Barcelona, España.
Centro de atención a las drogodependencias. Hospital de Mataró. Barcelona, España.
3
Servicio de Urgencias. Hospital de Mataró. Barcelona, España.
2
CHANGES IN BODY WEIGHT AMONG BIPOLAR PATIENTS PARTICIPATING IN A
RANDOMIZED, PLACEBO-CONTROLLED TRIAL (RCT) OF VARENICLINE FOR SMOKING
CESSATION
1.2
2
3
2
De Matteis M , Clinebell K , Rai A ; Chengappa KNR
1
Hospital General Universitario Gregorio Marañon, Madrid, España.
2
UPMC, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.
3
St. Mary's Mercy hospital, Livonia, MI, USA.
EFFECTS ON BRAIN FUNCTION OF USE OF MARIJUANA IN SCHOOLBOYS EVIDENCED BY
NEUROPSYCHOLOGICAL TESTING SHOWN BY NEURO-SPECT IMAGES
2
1
2
2
1
Ismael Mena , Anneliese Dörr , Sandra Viani , Sonia Neubauer , María Elena Gorostegui ,
1
3
María Paz Dörr , Diana Ulloa
1
Facultad de Medicina, Universidad de Chile, Chile.
2
Clínica Las Condes, Santiago, Chile.
3
Facultad de Ciencias Sociales, Universidad de Chile, Chile.
MARIJUANA TEEN CONSUMERS: IMPLICATIONS FOR FAMILY AND SCHOOL
Anneliese Dörr, M. Elena Gorostegui, Sandra Viani, M. Paz Dörr B.
1
Universidad de Chile, Facultad de Medicina, Santiago de Chile, Chile.
2
Universidad Católica de Chile, Facultad de Psicología, Santiago de Chile, Chile.
3
Hospital Clínico, Universidad Católica de Chile, Santiago de Chile, Chile.
PALIPERIDONE PALMITATE. AN EXPERIENCE IN DUAL PATHOLOGY
R. Salmons Aleu, T. Borràs Cabacés
Hospital Universitario S. Joan, Reus, Tarragona, España.
FAMILIAL FACTORS ASSOCIATED WITH DEVELOPMENT OF ALCOHOL AND MENTAL HEALTH
COMORBIDITY
C.L. Salom, G.M. Williams, J.M. Najman, R. Alati
University of Queensland, Brisbane, Australia.
SEX DIFFERENCES IN THE EFFECTS OF IMMUNE ACTIVATION DURING THE GESTATIONAL
STAGE ON COCAINE SELF-ADMINISTRATION IN ADULTHOOD: PRELIMINARY DATA FROM A
MODEL OF DUAL DIAGNOSIS
R. Santos-Toscano, D. Roura-Martínez, M. Ucha-Tortuero, MA. Assís, M. Miguéns, E.
Ambrosio, A. Higuera-Matas
UNED. Madrid, España.
APPROACH TO DUAL PATHOLOGY IN THE PSYCHIATRIC HOSPITAL
Juan Rosales
Mexican Academy of Dual Pathology, Mexico.
www.cipd2015.com
Pág. 32
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
13:30 – 15:00
Auditorium A
Track: Attention Deficit
Invited Symposium - IS10
ADHD AS A CAUSAL FACTOR IN DUAL DISORDERS
Chair:
Miquel Roca, Universidad de las Islas Baleares. Mallorca, España.
Speakers:
GENETIC RISK FOR ADD IN ADDICTED PATIENTS
Josep A. Ramos Quiroga, Hospital Universitari Vall d'Hebron. Barcelona, España.
INFLUENCE OF ADHD IN ADDICTION EVOLUTION
Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA.
NEED OF TREATMENT IN DUAL ADHD
José Martínez-Raga, Unidad de Conductas Adictivas de Gandia, CEU Cardenal Herrera.
Valencia, España.
13:30 – 15:00
Room 1
Track: Psychosis
Invited Symposium - IS11
SHARED VULNERABILITY TO DUAL DISORDERS, PSYCHOSIS AND CANNABIS ADDICTIONS
Chair:
Julio Vallejo, Universidad de Barcelona, España.
Speakers:
CANNABIS IN FIRST EPISODE PSYCHOTIC PATIENTS
Miquel Bernardo, Hospital Clínico. Universitat de Barcelona, España.
NEUROIMAGING IN DUAL DISORDER PATIENTS CONSUMERS OF CANNABIS
Benedicto Crespo- Facorro, Hospital Universitario Marqués de Valdecilla. Santander, España.
FOLLOW UP, CANNABIS IN-TAKE AND THE PSYCHOSIS EVOLUTION
Ana González Pinto, Hospital Santiago Apóstol. Vitoria, España.
13:30 – 15:00
Room 4
Track: Cannabis and
Dual Disorders
Symposium – SY36
THINGS TO KNOW OF CANNABIS CONSUMPTION IN DUAL PATIENTS
Chair:
Mercedes Balcells, Hospital Clínic I Universitari De Barcelona. Barcelona, España.
Speakers:
INSTRUMENTS FOR ASSESSING CANNABIS USE IN PSYCHIATRIC PATIENTS
Hugo López-Pelayo, Grup de Recerca En Addicions Clínic. Hospital Clínic i Universitari de
Barcelona. Barcelona, España.
COGNITIVE IMPAIRMENT IN CANNABIS USERS: FROM RESEARCH TO CLINICAL PRACTICE
Albert Batalla-Cases, Tactus Addiction Treatment. Deventer, The Netherlands.
CANNABINOID HYPEREMESIS SYNDROME: EPIDEMIOLOGY, ASSESSMENT AND
DIFFERENTIAL DIAGNOSIS
Laia Miquel, Grup de Recerca en Addicions Clínic. Hospital Clínic i Universitari de Barcelona.
Barcelona, España.
PSYCHOACTIVE COMPONENTS OF CANNABIS AND THEIR CLINICAL IMPLICATIONS
Cristina Casajuana, Grup De Recerca En Addicions Clínic. Hospital Clínic i Universitari de
Barcelona. Barcelona, España.
www.cipd2015.com
Pág. 33
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
13:30 – 15:00
Room 5
Track: Eating Disorders
Invited Symposium – IS12
FOOD AND DRUGS: BINGE-EATING DISORDERS
Chair:
Ignacio Basurte, Hospital General Universitario Gregorio Marañón. Madrid, España.
Speakers:
IS EATING DISORDER AN ADDICTIVE DISORDER?
Luis Rojo Moreno, Hospital Universitario y Politécnico La Fe. Valencia, España.
Luis Rojo Bofill, Servicio de Psiquiatría. HU La Fe, Valencia, España.
IS BINGE EATING DISORDER AN EVOLUTION OF THE ADDICTION?
Francisco J. Vaz, Complejo Hospitalario Universitario UNEX. Badajoz, España.
SYMPTOMS OF ADHD IN ED AS A RISK FACTOR FOR DD
Marina Díaz Marsá, Hospital Clínico San Carlos. Madrid, España.
13:30 – 15:00
Room 6
Track: Planning,
regulations and
resource management
Symposium – SY37
CARE PATTERNS IN DUAL PATHOLOGY. NEARING ITS EFECTIVENESS AND EFFICIENCY
THROUGH THE FOLLOW UP OF PATIENTS?
Chair:
Indalecio Carrera, Asociación Ciudadana de Lucha contra la Droga (ACLAD). A Coruña,
España.
Speakers:
SPECIFIC INTERVENTIONS IN THE UPD OF COIMBRA
Carla Torres, Unidade de Patologia Dual, Centro Hospitalar Universitário de Coimbra,
Portugal.
DUAL PATHOLOGY IN ADDICTION NETWORKS OF HEALTH AREAS IN PORTO AND CORUÑA
José A. Santos, Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências
(SICAD), Portugal.
THE DUAL PATHOLOGY IN MENTAL HEALTH NETWORK IN LA CORUÑA
Mª Carmen García, Complejo Hospitalario Universitario de A Coruña, Universidad de Santiago
de Compostela. Galicia, España.
ANALYSIS OF CARE MODELS AND PROPOSALS FOR IMPROVING THEIR QUALITY
Indalecio Carrera, Asociación Ciudadana de Lucha contra la Droga (ACLAD). A Coruña,
España.
13:30 – 15:00
Room 7
Track: Sick Doctors
and Dual Disorders
Symposium - SY38
CARE PROGRAM FOR SICK PHYSICIANS: HEALTH AND QUALITY INTERVENTION
Chair:
Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real.
Castilla la Mancha, España.
Speakers:
PAIME REPORT. FUTURE WORK LINES
Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real.
Castilla la Mancha, España.
THE PSYCHOLOGIST ROLE IN PAIME. INTERVENTION STRATEGIES BASED ON MEDICAL
ASSOCIATIONS
Isabel Montoya, Psicologa Clinica del PAIME de Ciudad Real. Castilla la Mancha, España.
www.cipd2015.com
Pág. 34
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
PATIENT PAIME: DESIGN SOCIAL PROTECTION
Nina Mielgo, Fundación Protección Social Médicos Príncipe de Asturias. Oviedo, España.
13:30 – 15:00
Room 8
Track: Behavioral
addictions / Gambling
Disorders
Symposium – SY39
GAMBLING DISORDERS AND PSYCHOTIC DUAL DISORDERS (SCHIZOPHRENIA)
Chair:
Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia,
España.
Speakers:
PSYCHIATRIC COMORBIDITY ASSOCIATED WITH PATHOLOGICAL GAMBLING
Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia,
España.
CLINICAL AND PSYCHIATRIC IMPLICATIONS OF PATHOLOGICAL GAMBLING IN
SCHIZOPHRENIA
Gemma Parramon, Hospital Universitari Vall d'Hebron. Barcelona, España.
PSYCHOLOGICAL IMPLICATIONS OF SCHIZOPHRENIA IN PATHOLOGICAL GAMBLING.
Montserrat Gómez, Asociación Barcelonesa de Ludopatía y Adicciones/ Instituto de
Diagnostico Psicológico, Barcelona, España.
13:30 – 15:00
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
13:30 – 15:00
Room 10
Track: Planning,
regulations and
resource management
Symposium – SY40
TREATMENT SYSTEMS/SERVICES FOR DUAL DISORDERS: EXPERIENCES IN DIFFERENT
COUNTRIES
Chair:
Christian G. Schütz, University of British Columbia. Vancouver, Canada.
Co-chair:
Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat
Autònom, Barcelona, España.
Speakers:
THE TREATMENT OF DUAL DISORDER PATIENTS IN SWITZERLAND
Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàctel, Switzerland.
THE RESTRUCTURING OF DUAL DIAGNOSES HEALTH CARE IN THE BRITISH COLUMBIA,
CANADA: IS THE PATH THE GOAL?
Christian G. Schütz, University of British Columbia. Vancouver, Canada.
CONTRASTING DUAL DIAGNOSES APPROACHES IN AUSTRALIA TO APPROACHES IN OTHER
CONTINENTS
Enrico Cementon, University of Melbourne. Melbourne VIC, Australia.
13:30 – 14:15
Room 11
Track: Cannabis and
Dual Disorders
Workshop - WS10
DUAL DISORDERS AND LIBERALISM
Chair/ Speaker:
Susana E. Méndez, Enterhealth, Residential and Outpatient Services, Dallas TX, USA.
www.cipd2015.com
Pág. 35
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
14:15 – 15:00
Room 11
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Workshop - WS11
COGNITIVE-AFFECTIVE MECHANISMS INVOLVED IN THE INTERPRETATION OF DRUG USE IN
DUAL DISORDERS
Chair:
Humberto Guajardo, Universidad de Santiago de Chile. Santiago de Chile, Chile.
Speakers:
POSRACIONALISTIC PERSPECTIVE IN DUAL PATHOLOGY
Humberto Guajardo, Universidad de Santiago de Chile. Santiago de Chile, Chile.
INTERPRETATED EFFECT ON DRUG ABUSE
Diana Kushner, Universidad de Santiago de Chile. Santiago de Chile, Chile.
13:30 – 15:00
Room 12
Oral Communications – OC07
Chairs:
Carolina Franco, Centre d´Higiene Mental Les Corts. Barcelona, España.
Enrique Mendoza, Asociación Psiquiátrica de América Latina (APAL), Guatemala.
HIGHER FREQUENCY OF C.3435 OF THE ABCB1 GENE IN PATIENTS WITH TRAMADOL
DEPENDENCE DISORDER
1
1
2
Dalia Enaba , Heba El Baz , Hamdy Moselhy
1
Psychiatry Department and Chemical Pathology Department, Faculty of Medicine, Cairo
University, Cairo, Egypt.
2
Medicine, UAE University, Al Ain, United Arab Emirates.
THE BINOMIAL VIOLENCE AND ALCOHOL
P.M. Fuertes
Psychology. Astorga. León, España.
ENERGY DRINKS: AN EMERGING HEALTH PROBLEM
Sara Meca Zapatero
Centro G. SINadicciones, (Gabinete Psicológico especializado en la Prevención y
Rehabilitación de Conductas Adictivas, Psicología Clínica y Patología Dual) Valencia, España.
DETOXIFICATION WITH METHADONE FOR THE TREATMENT OF PRESCRIPTION OPIOID USE
DISORDER: TWO CLINICAL CASES
1
1
1,2
Oriolo G , Barrio P , Balcells M
1
Institut Clínic of Neuroscience (ICN). Hospital Clínic de Barcelona, Catalonia, España.
2
Institut d’Investigacions Biomédiques August Pi i Sunyer (IDIBAPS). España.
BACLOFEN : MAINTENANCE OF ABSTINENCE IN ALCOHOL DEPENDENT PATIENTS
ATTENDING LIVER CLINIC
1
2
2
1
2
Lynn Owens , Abi Rose , Andrew Thompson , Ian Gilmore , Munir Pirmohamed , Paul
1
Richardson
1
Royal Liverpool Hospital Trust. United Kingdom.
2
University of Liverpool. United Kingdom.
www.cipd2015.com
Pág. 36
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
DUAL PATHOLOGY ON ALCOHOLIC PEOPLE: A DESCRIPTIVE STUDY
1
2
3
4
M.A. García Carretero , M. Robles Martínez , M.A. Jordán Quintero , J. Gibert Rahola
1
CTS391 Grupo Multidisciplinar para el progreso de la Salud Mental, Universidad de Cádiz,
España.
2
CTA ARCA y Hospital Universitario Puerta del Mar, Cádiz, España.
3
Hospital Universitario Puerta del Mar, Cádiz, España.
4
CTA ARCA y Departamento Neurociencias, Universidad de Cádiz, España.
INJECTION AND NON INJECTION DRUG USERS PRESENTING IN A TEACHING HOSPITAL IN
SOKOTO, NIGERIA. A REPORT OF SOCIOCULTURAL FACTOR AS BARRIER IN MANAGEMENT
1,2
1,2
M.A. Yunusa , A. Obembe
1
Usman Danfodiyo University, Sokoto, Nigeria.
2
Usman Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
DIFFERENCES BETWEEN OPIATE AND NON-OPIATE USING POPULATIONS:
CHARACTERISTICS, MOTIVATION, RETENTION AND OUTCOMES IN DUAL DIAGNOSIS
TREATMENT
Siobhan A. Morse
Foundations Recovery Network in Nashville, Tennessee, USA.
THE ASSOCIATION BETWEEN GRIT AND DUAL DIAGNOSIS AMONG INPATIENTS WITH
ALCOHOL USE DISORDERS
1,2
1.2
M.L. Griffin ; R.D. Weiss
1
Harvard Medical School, Boston, Massachusetts, USA.
2
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts, USA.
15:00 – 16:30 h.
15:00 – 15:45
Auditorium A
Track: Basic Research
Main Lecture – ML10
ADHD AND ADDICTIONS, A PATTERN OF DUAL DISORDERS
Chair:
Francisco de Asís Babín, Plan Nacional Sobre Drogas, España.
Speaker:
Nora Volkow, National Institute on Drug Abuse (NIDA), Bethesda. MD, USA.
15:45 – 16:30
Auditorium A
Track: Attention Deficit
Main Lecture – ML11
NEW PHARMACOLOGICAL APPROACHES IN ADHD AND DUAL DISORDERS
Chair:
Carlos Mur, Hospital Psiquiátrico José Germain, Leganés, España.
Speaker:
Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA.
15:00 – 16:30
Invited Symposium - IS13
www.cipd2015.com
Pág. 37
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Room 1
Track: Behavioral
Addictions / Gambling
Disorders
THE HOUSE IS ON FIRE: GAMBLING DISORDERS AND DUAL PATHOLOGY
Chair:
Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España.
Speakers:
INTERNET USE AND DUAL DISORDER
Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France.
GAMBLING RISKS AND DUAL DISORDERS
Nady El-Guebaly, University of Calgary. Alberta, Canada.
ADDICTION TO ‘SMART PHONE’
Mariano Choliz, Universidad de Valencia, España.
15:00 – 16:30
Room 2-3
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Symposium – SY41
RIOD: EMERGING NEEDS IN DUAL PATHOLOGY IN DEVELOPING IBEROAMERICAN
COUNTRIES
Chair:
Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina.
Co-chair:
Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real.
Castilla la Mancha, España.
Speakers:
PRESENTATION OF RIOD (RED IBEROAMERICANA DE DROGODEPENDENCIAS)
Felisa Pérez, Red Iberoamericana de Drogodependencias, Madrid, España.
Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina.
15:00 – 16:30
Room 4
Track: Cannabis and
Dual Disorders
Symposium – SY42
CANNABIS, CANNABINOIDS AND DUAL PSYCHIATRIC DISORDERS
Chair:
Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel.
Speakers:
A LONGITUDINAL EXPLORATION OF THE IMPACT OF CANNABIS USE ON INCIDENCE AND
COURSE OF ILLNESS OF MOOD DISORDERS
Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel.
CLINICAL CHARACTERISTICS OF HOSPITALIZED SYNTHETIC CANNABINOID USERS
Gal Shoval, Geha Mental Health Center, Tel Aviv University. Tel Aviv, Israel.
CANNABIS USE AND HALLUCINOGEN PERSISTING PERCEPTION DISORDER: A CASE SERIES
Arturo Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv,
Israel.
15:00 – 16:30
Room 5
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium – SY43
DRUG USE HAS NO AGE LIMIT. DUAL PSYCHOPATHOLOGY AND INTEGRATED TREATMENT
APPROACH IN OLD-AGE
Chair:
Antonio Bulbena, Parc de Salut Mar, Universitat Autònoma de Barcelona. Barcelona, España.
Speakers:
PSYCHOPATHOLOGY IN GERIATRICS
www.cipd2015.com
Pág. 38
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Manuel Sánchez, Unidad de Psiquiatría Geriátrica, Hospital Sagrat Cor Martorell. Barcelona,
España.
INTEGRATED APPROACH TO THE ELDERLY PATIENT
Ángel Moríñigo, Psiquiatra Ejercicio Privado. Sevilla, España.
DRUG USE HAS NO AGE LIMIT
Elena Ros-Cucurull, Hospital Universitari Vall d’Hebron. Barcelona, España.
15:00 – 16:30
Room 6
Track: Alcohol
Symposium – SY44
CLINICAL IMPLICATIONS OF DRUG CONSUMPTION: INFLUENCE OF DUAL PATHOLOGY
Chair:
Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland.
Speakers:
ASSESSMENT OF PSYCHIATRIC COMORBIDITIES IN AN OPIATE INTEGRATED TREATMENT IN
HO CHI MINH, VIETNAM
Jean-Pierre Daulouede, Centre Hospitalier de la CA'te Basque, Bayonne, France.
RELATIONSHIP BETWEEN CANNABIS AND PSYCHOSIS: A DANGEROUS LINK?
Logos Curtis, Unité de psychiatrie du jeune adulte (JADE), Service de Psychiatrie Générale,
Département de Santé mentale, Hôpitaux Universitaires de Genève, Switzerland.
BRIEF INTERVENTIONS IN ALCOHOLISM; ARE THEY USEFUL IN DUAL PATIENTS?
Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland.
15:00 – 16:30
Room 7
Track:
Psychopharmacological
Treatments in Dual
Disorders
Symposium – SY45
CLOZAPINE FOR SCHIZOPHRENIA AND CO-OCCURRING SUBSTANCE USE: WORTH A SECOND
LOOK?
Chair:
Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA.
Speakers:
CLOZAPINE FOR SUBSTANCE USE DISORDERS IN SCHIZOPHRENIA: CURRENT KNOWLEDGE
AND A UNIFYING HYPOTHESIS
Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA.
WHAT IS UNUSUAL ABOUT CLOZAPINE?
Torgny Svensson, Karolinska Institute. Solna, Sweden.
COMPARING THE EFFECT OF CLOZAPINE AND RISPERIDONE ON CANNABIS REWARD IN
PATIENTS WITH SCHIZOPHRENIA AND CANNABIS USE DISORDER: A RANDOMIZED FMRI
STUDY
Marise Machielsen, Academic Psychiatric Center. Amsterdam, The Netherlands.
TOWARD A VALID ANIMAL MODEL OF ALCOHOL USE DISORDER IN SCHIZOPHRENIA:
CLOZAPINE REDUCES ALCOHOL DRINKING IN THE NEONATAL VENTRAL HIPPOCAMPAL
LESIONED RAT
Jibran Khokhar, Geisel School of Medicine at Dartmouth. Hanover NH, USA.
www.cipd2015.com
Pág. 39
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
15:00 – 16:30
Room 8
Track: Post-Traumatic
Stress
Symposium – SY46
TRAUMA CARE FOR THE MOST VULNERABLE
Chair:
Michael Krausz, University of British Columbia. Vancouver, Canada.
Speakers:
ADDICTION, TRAUMA, MENTAL ILLNESS - TREATMENT OPTIONS FOR COMPLEX
CONCURRENT DISORDERS
Michael Krausz, University of British Columbia. Vancouver, Canada.
GENDER IDENTITY DISORDER & SUD: LET'S GO DEEP INTO THE ABYSS OF TRAUMA
Ester di Giacomo, Department of Translational Medicine and Surgery-University of Milano,
Italy.
TRAUMA EXPERIENCES, AFFECTIVE INESTABILITY, BIPOLAR DISORDER AND ASSOCIATED
SUBSTANCE USE: UN-DERLYING MECHANISM AND THERAPEUTIC CONSEQUENCES
Christian G. Schütz, University of British Columbia. Vancouver, Canada.
15:00 – 16:30
Room 9
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
15:00 – 16:30
Room 10
Track: Epidemiology
and Dual Disorders
Symposium - SY47
IDENTIFYING PSYCHIATRIC PATIENTS VULNERABLE TO SUBSTANCE MISUSE
Chair:
Manuel Gurpegui, Universidad de Granada, España.
Speakers:
AN OVERVIEW OF THE OVERLAP BETWEEN PSYCHIATRIC DISORDERS AND VARIETIES OF
SUBSTANCE MISUSE
José M. Martínez-Ortega, Instituto de Neurociencias, Universidad de Granada. Granada,
España.
WHO ARE THE PATIENTS WITH DEPRESSION MORE LIKELY TO ABUSE ALCOHOL?
Conor K. Farren, Trinity College Dublin, St Patrick's University Hospital. Dublin, Ireland.
HOW DO PATIENTS WITH BIPOLAR DISORDER OR SCHIZOPHRENIA DIFFERENTIALLY REACT
TO OPIATES OR STIMULANTS?
Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital,
Pisa, Italy.
ARE PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER ADDICTED TO TOBACCO A
DIFFERENT SUBPOPULATION WITHIN THEIR DIAGNOSTIC GROUP?
Manuel Gurpegui, Universidad de Granada, España.
15:00 – 15:45
Room 11
Track: Suicide & Dual
Disorders
Workshop - WS12
VIOLENCE AND SELF-VIOLENCE IN DUAL DISORDERS
Chair:
Speakers:
SELF-VIOLENCE IN DUAL DISORDERS
Mª Dolores Braquehais, Hospital Universitari Vall d'Hebron. Universitat Autònoma de
Barcelona. CIBERSAM. Barcelona, España.
NEUROBIOLOGY OF SUICIDAL BEHAVIOR IN ADOLESCENTS WITH DUAL DISORDERS
www.cipd2015.com
Pág. 40
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Mª Dolores Picouto, Sant Joan de Déu University Hospital, Universitat de Barcelona.
Barcelona, España.
15:45 – 16:30
Room 11
Track:
Psychopharmacological
Treatments in Dual
Disorders
Workshop - WS13
GUIDELINES FOR THE PHARMACOLOGICAL AND PSYCHOLOGICAL TREATMENT OF ADULT
PATIENTS WITH A PSYCHIATRIC DISORDER AND A COMORBID SUBSTANCE USE
Chair:
Miquel Bernardo, Hospital Clínico. Universitat de Barcelona. Barcelona, España.
Speaker:
DEVELOPMENT OF THE CLINICAL GUIDELINE OF DUAL PATHOLOGY: GROUP COMPOSITION,
MEETINGS, PICO QUESTIONS, ASSESSMENT OF THE SCIENTIFIC EVIDENCE USING THE
GRADE SYSTEM, AND RECOMMENDATIONS
Luis San, Sant Joan de Deu. Barcelona, España.
15:00 – 16:30
Room 12
Oral Communications - OC08
Chairs:
Arkaitz Aguerretxe, Cabinet en Libéral, BIZIA/SETHS, CSAPA BIZIA/Medecins du Monde,
France.
Elvia Velásquez, Alad (Latinoamerican Association on Addiction). Colombia.
PERSONALITY DISORDER AND ADDICTION
1
2
1
3
2
S. Božović , J.Đorđević , S. Čelebić , D. Pavlović , M. Prvulović
1.
Special Hospital for Substance Abuse, Belgrade, Serbia.
2.
Hospital for Psychiatric Diseases”Dr L Lazarević”, Belgrade, Serbia.
3.
Faculty of special education and rehabilitation, Belgrade, Serbia
ADOLESCENT SMOKING AND SYMPTOMS OF DEPRESSION/ANXIETY: EVIDENCE FOR A SELFMEDICATION HYPOTHESIS
1
1
1,2
N. Carceller-Maicas , A. Martinez-Hernaez , Susan DiGiacomo
1
Universitat Rovira i Virgili. Tarragona, España.
2
University of Massachusetts at Amherst, USA.
RESEARCH OF THE COMORBIDITY BETWEEN BORDERLINE PERSONALITY DISORDER,
ATTENTION DEFICIT HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDER IN AN
ADULT PATIENTS SAMPLE
1,2
1
1,4
3
3
C. Maruottolo , A. González , O. Landeta Rodríguez , J. Balerdi , M. Fernández , A.
3
Hernández
1
AMSA-Teaching and Research Unit, Bilbao, Bizkaia, España.
2
Medicine Faculty, Universidad País Vasco, Bizkaia, España.
3
AMSA Unidad de Día, Bilbao, Bizkaia, España.
4
UNED-Bizkaia, Bizkaia, España.
STUDY OF THE EFFECTIVENESS OF A PSYCHODYNAMIC AND SOCIODYNAMIC TREATMENT
IN PATIENTS WITH DUAL PATHOLOGY
1,2
1,3
4
C. Maruottolo Sardella , O. Landeta Rodríguez , C. LLorrens Herrera
www.cipd2015.com
Pág. 41
Sunday April 19th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
1
AMSA-Teaching and Research Unit, Bilbao, Bizkaia, España.
Medicine Faculty, Universidad País Vasco, Bizkaia, España.
3
AMSA Unidad de Día, Bilbao, Bizkaia, España.
4
UNED-Bizkaia, Bizkaia, España.
2
THE RELATIONSHIP BETWEEN VULNERABLE ATTACHEMENT STYLE, PSYCHOPATHOLOGY,
DRUG ABUSE, AND RETENTION IN TREATMENT AMONG METHADONE MAINTENANCE
TREATMENT PATIENTS
1,2
1,3
1
1
1,3
D. Potik , E. Peles , Y. Abramsohn , M. Adelson , S. Schreiber
1
Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and Research, Tel-Aviv
Sourasky Medical Center, Tel-Aviv, Israel.
2
Department of Psychiatry, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
3
Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
TREATMENT OUTCOMES IN A DUAL DIAGNOSIS THERAPEUTIC COMMUNITY: A FOLLOW-UP
STUDY
Virginio Salvi, Fabrizio Boccardo, Patrizia Giannini, Metello Corulli
Comunità Terapeutica “Il Porto” ONLUS, Moncalieri (TO), Italy.
SELF HARM AMONG WOMAN INJECTING DRUG USERS (IDUS) FROM NORTH EASTERN
INDIA
Kimneihat Vaiphei
St.Johns Medical College and Hospital, India.
16:30 - 17:30 h.
16:30 – 17:15
Auditorium A
Track: Bipolar Disorders
Plenary Session - PS03
ON THE BLINK: BIPOLAR AND DUAL DISORDERS
Chair:
Enrique Álvarez, Hospital San Pau de Barcelona, España.
Speaker:
Eduard Vieta, Hospital Clínic de Barcelona. Universitat de Barcelona. España.
17:15 – 17:30
Auditorium A
SESSION AWARD FOR BEST POSTER WINNER
www.cipd2015.com
Pág. 42
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
08:30 – 10:00 h.
08:30 – 10:00
Room 2
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium – SY48
RESOURCE OPTIMIZATION FOR PATIENTS WITH DRUG ADDICTION DUAL DISORDERS
Chair:
Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real.
Castilla la Mancha, España.
Speakers:
HOSPITAL COORDINATION: ANOTHER WAY OF DUAL PATIENTS TO UCA ACCESS
Gloria Cordeiro-Crespo, Servicio de Psiquiatría Mancha Centro de Alcázar de San Juan.
Ciudad Real, España.
FLOOR SUPPORT THERAPY IN DUAL PATHOLOGY PATIENTS
Paloma Sánchez, Unidad de Conductas Adictivas. Ciudad Real, España.
IMPROVING ADHERENCE OF DUAL PATIENTS : FROM THE STREET WORKER TO THE UCA
Mª Luisa Celorrio, Complejo Hospitalario Universitario de Albacete. Albacete, España.
08:30 – 10:00
Room 3
Track: Tobacco
Symposium – SY49
TOBACCO AND DUAL PATHOLOGY: TOOLS FOR ACTION
Chair:
César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis
Ortega en la Isla de Margarita, Venezuela.
Speakers:
SMOKING IN PSYCHIATRIC PATIENTS: NEGLECTED EPIDEMIC
Débora Serebrisky, Centro de Investigaciones Clínicas WM. Argentina.
DUAL ADDICTION: NICOTINE AND COCAINE DEPENDENCE
Iván Montoya, Division of Pharmacotherapies and Medical Consequences of Drug Abuse,
NIDA, USA.
SMOKING AND PATHOLOGICAL GAMBLING
César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis
Ortega en la Isla de Margarita, Venezuela.
SMOKING AND MENTAL HEALTH PROFESSIONALS IN ARGENTINA
Fernando Müller, Proyecto MEDEF, Centro de Investigaciones Clínicas WM, APSA, EGAMA,
Unión Antitabáquica Argentina, Argentina.
08:30 – 10:00
Room 4
Track: Training in
Dual Diagnosis
New Forum - NF01
STATE OF DUAL DISORDER TRAINING, CLINICAL SERVICES AND RESEARCH ACROSS
COUNTRIES
Chair:
Yatan Pal Singh, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Speakers:
STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS
IN FRANCE
www.cipd2015.com
Pág. 43
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Amine Benyamina, Centre D'Enseignement, de Recherche Et de Traitement des Addictions.
Paris, France.
THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL
DISORDERS IN ISRAEL
Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel.
THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL
DISORDERS IN SPAIN
José Martínez-Raga, Hospital Universitario Doctor Peset y Universitat de Valencia, España.
THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL
DISORDERS IN INDIA
Yatan Pal Singh, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
08:30 – 10:00
Room 5
Track: Sleep
Disorders and
Dual Diagnosis
Symposium – SY50
AM I AWAKE OR ASLEEP? SLEEP DISORDERS IN DUAL PATHOLOGY
Chair:
Carmen Barral, Hospital Universitari Vall d'Hebron. Barcelona, España.
Speakers:
NEUROPHYSIOLOGY OF SLEEP AND ITS DISORDER ADDICTION
Fermín Ordoño, Hospital Arnau de Vilanova. Lleida, España.
RELATIONS BETWEEN SLEEP AND ADDICTIONS
Francesca Cañellas, Hospital Son Dureta. Palma de Mallorca, España.
TREATMENT OF SLEEP DISORDERS IN DUAL PATIENTS
Lara Grau-López, Hospital Universitari Vall d’Hebron. Barcelona, España.
08:30 – 10:00
Room 6
Track: Penitentiary
(Prisons) and Dual
Disorders
Symposium – SY51
VIOLENCE IN DUAL DISORDERS: NEURAL CORRELATES AND TREATMENT
Chair:
Alessandra Cappai, Maudsley National Health Service Foundation Trust. London, United
Kingdom.
Speakers:
VIOLENCE AND SUBSTANCE MISUSE
Alessandra Cappai, Maudsley National Health Service Foundation Trust. London, United
Kingdom.
TREATMENT OF VIOLENCE
Mrigendra Das, Broadmoor Hospital, West London Mental Health NHS Trust, Oxford School of
Psychiatry. London, United Kingdom.
VIOLENCE AND NEURAL CORRELATES
Carlos Parro, C.S. Mental Retiro. Hospital Universitario Gregorio Marañón. Madrid, España.
08:30 – 10:00
Room 7
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium – SY52
ADDICTION: UNCOVERING NEUROBIOLOGICAL COMPLEXITY
Chair:
José E. Montejo, Universitat Autònoma de Barcelona. Hospital Universitari Vall d'Hebron.
Barcelona, España.
Speakers:
www.cipd2015.com
Pág. 44
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
HOW THE ENVIRONMENT INTERACTS WITH GENES IN DRUG ADDICTION
Bru Cormand, Universidad de Barcelona. Barcelona, España.
NEUROPLASTICITY IN DRUG ADDICTION: INTERACTIVE SYSTEM OF MOLECULAR
COMMUNICATION
Julio Campos, Neuropsychiatric Research Lab. Universidad Central de Venezuela. Caracas,
Venezuela.
NEUROBIOLOGICAL COMPLEXITY
Ruben Baler, National Institute on Drug Abuse. MD, USA.
THERAPEUTICS IN ADDICTION: WHAT IS THE TARGET?
José E. Montejo, Universitat Autònoma de Barcelona. Hospital Universitari Vall d'Hebron.
Barcelona, España.
08:30 – 10:00
Room 8-9
Track: Behavioral
Addictions / Gambling
Disorders
Invited Symposium - IS14
GAMBLING AND DUAL DISORDERS. WHAT YOU ALWAYS WANT TO KNOW ABOUT
BEHAVIORAL ADDICTIONS
Chair:
Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España.
Speakers:
EATING DISORDERS AND BEHAVIORAL ADDICTIONS. MEET WITH THE UNEXPERT
Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España.
EPIDEMIOLOGY GAMBLING DISORDER AND DRUG DEPENDENCE
Enrique Echeburua, Facultad de Psicología-Universidad País Vasco, España.
GAMBLING DISORDER TREATMENT
Susana Jiménez, Hospital Universitario de Bellvitge-IDIBELL. Barcelona, España.
08:30 – 09:15
Room 10
Track: Sexual
Dysfunction and Dual
Disorders
Workshop - WS14
SEXUAL DYSFUNCTION AND SEXUAL HEALTH NEEDS OF PEOPLE WITH DUAL DISORDER:
EVIDENCE AND PRACTICE
Chair:
Elizabeth Hughes, University of York. York, United Kingdom.
Speakers:
SEXUAL HEALTH NEEDS OF PEOPLE WITH DUAL DISORDERS
Elizabeth Hughes, University of York. York, United Kingdom.
SEXUAL DYSFUNCTION AS A SIDE -EFFECT OF PSYCHOTROPIC MEDICINES FOR PEOPLE WITH
DUAL DISORDERS
Ian Hamilton, University of York. York, United Kingdom.
09:15 – 10:00
Room 10
Track:
Psychotherapeutic
Treatment in Dual
Disorders
Workshop - WS15
MAKING TREATMENT MORE ACCESSIBLE FOR PEOPLE WITH DUAL DISORDERS
Chair/ Speaker:
Jim Bott, Roosevelt Hospital, NY, USA.
www.cipd2015.com
Pág. 45
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
08:30 – 09:15
Room 11
Track: Multidisciplinary
Intervention in Dual
Disorders
Workshop – WS16
TREATING DUAL DISORDERS IN YOUNG ADULTS WITH A MULTIDISCIPLINARY NONCONVENTIONAL STRUCTURED APPROACH
Chair/ Speaker:
Susana E. Méndez, Enterhealth, Residential and Outpatient Services, Dallas TX, USA.
09:15 – 10:00
Room 11
Track: Alcohol
Workshop – WS17
ALCOHOLISM IN ASIA: INCREASE IN PSYCHIATRY COMORBIDITY AND ITS COMORBID
DISORDERS
Chair:
Aravind Vaithiyam, Ram Psychiatry Hospital. Madurai, India.
Speakers:
ALCOHOLISM IN INDIA
Aravind Vaithiyam, Ram Psychiatry Hospital. Madurai, India.
RELAPSE PREVENTION IN ALCOHOLISM - PHARMACOLOGICAL MANAGEMENT
Sujai Subramanian, Aashiana Psychiatric Care Hospital. Delhi, India.
OVERLOOKED AND OVERDIAGNOSED COMORBID DEPRESSION IN ALCOHOLISM
Takahiko Inagaki, Shiga University of Medical Science. Shiga, Japan.
08:30 – 10:00
Room 12
Oral Communications - OC09
Chairs:
Amanda Rodríguez, Vall d'Hebron University Hospital, Barcelona, Spain.
Jorge Ocampo, Mexican Academy of Dual Pathology (AMEPAD), Mexico.
POSTTRAUMATIC STRESS SYMPTOMS AND RELATIONSHIP TO DRUG AND ALCOHOL USE IN
AN INTERNATIONAL SAMPLE OF LATIN AMERICAN IMMIGRANTS
1
1
2
1
Lisa R. Fortuna , Ye Wang , Michelle Porche , Zorangeli Ramos
1
Center for Multicultural Mental Health Services Research, Cambridge Health Alliance,
Cambridge, MA, USA.
2
Wellesley Centers for Women, Wellesley College, Wellesley. MA, USA.
THERAPEUTIC ITINERARY IN SITUATIONS OF COMORBIDITY: INTEGRATION AND EQUALITY
IN THE HEALTH SYSTEM - BRAZIL
A. Assis, M. Silva
State University of Rio de Janeiro – RJ, Brasil.
SEX TRADING AMONG MEN AND WOMEN ENTERING TREATMENT FOR DRUG MISUSE IN
ENGLAND: ASSOCIATIONS WITH MENTAL WELLBEING
1
2
2
1
G. Gilchrist , A. Jones , M. Donmall , N. Singleton
1.
King’s College London, London, United Kingdom.
2.
University of Manchester, Manchester, United Kingdom.
THE IMPACT OF RACIAL DISCRIMINATION ON SUBSTANCE USE IN THE LATIN AMERICAN
IMMIGRANT POPULATION
1
1
2
3
Alba-Irene González , Adriana Reyes , Zorangeli Ramos , Claudia González López , Francisco
www.cipd2015.com
Pág. 46
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
1
Collazos
1
Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, CIBERSAM, España.
2
Center for Multicultural Mental Health Research and Harvard Medical School, Boston. MA,
USA.
3
Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
EFFECTIVENESS OF THE PERSONAL STRENGTHS INTERVENTION (PSI) ON IMPROVING THE
STUDENTS WITH LEARNING DISABILITIES IN IRAN
S. Piryaei, M. Khademi Ashkezari
Alzahra University, Tehran, Iran.
SUBSTANCE USE AND THE PROTECTIVE EFFECT OF MATERNAL WARMTH
1,2
1
1
1
3
O. Santesteban , M. Ramos-Olazagasti , R. E. Eisenberg , H. R. Bird , G. Canino , C. S.
1
Duarte
1
Columbia University Medical Center - N.Y. Psychiatric Institute, New York, NY, USA.
2
Universitat Rovira i Virgili, Reus, Tarragona, España.
3
Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico.
THE STUDY OF AGGRESSION LEVEL IN PATIENTS WITH COMPUTER ADDICTION AND
COMORBID PSYCHIATRIC DISORDERS
1
1
2
1
D.C. Mavani , A.V. Dyachenko , V.A. Soldatkin , O.A. Bukhanovskaya
1
Scientific Center for Treatment and Rehabilitation "Phoenix", Rostov-On-Don, Russia.
2
Rostov State Medical University, Rostov-On-Don, Russia.
DUAL DIAGNOSIS IN PRIVATE PRACTICE IN MOROCCO
M. Paes
Mohamed V University in Rabat, Morocco.
10:00 – 11:30 h.
10:00 – 11:30
Room 2
Track: Cannabis and
Dual Disorders
www.cipd2015.com
Symposium – SY53
PATTERNS OF CANNABIS USE THROUGH THE LIFESPAN IN DUALLY AND NON-DUALLY
DIAGNOSED PATIENTS
Chair:
Nieves Martínez-Luna, Hospital Universitari Vall d’Hebron. Barcelona, España.
Speakers:
PATTERNS OF CANNABIS USE, AND THE PRESENCE OF DUAL DIAGNOSIS IN CHILDREN AND
TEENAGERS
Javier Goti, Hospital Clinic. Barcelona, España.
PATTERNS OF CANNABIS USE IN ADULTS -18 TO 55 YEARS- AND THE PRESENCE OF DUAL
DIAGNOSIS
Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy.
PATTERNS OF CANNABIS USE IN ADULTS -56 YEARS AND IN OLDER LIFE- AND THE
PRESENCE OF DUAL DIAGNOSIS
Pág. 47
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Begoña Gonzalvo, Centre d'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM.
Barcelona, España.
10:00 – 11:30
Room 3
Track: Sexual
Dysfunction
Invited Symposium - IS15
THE INTERCOURSE OF SEXUAL ADDICTION AND DUAL DISORDERS
Chair:
Josep Mª Farré, Hospital Universitario Quirón-Dexeus. Barcelona, España.
Speakers:
NEW TRENDS IN SEXUALITY AND DRUGS
José Antonio Navarro, Hospital Universitario Vall d’Hebron de Barcelona/Clínica Galatea.
Barcelona, España.
SEX ADDICTION: COMORBIDITY WITH DRUGS AND OTHER PATHOLOGIES
Josep Mª Farré, Hospital Universitario Quirón-Dexeus. Barcelona, España.
SEXUAL LIFE AFTER PSYCHOTROPIC DRUGS
Victoria Ferrer Olives, España.
10:00 – 11:30
Room 4
Track: Evaluation
processes in Dual
Disorders
Symposium – SY54
MEDICAL COMORBIDITY IN DUAL PATHOLOGY
Chair:
Maite San Emeterio, Centre d´Higiene Mental Les Corts. Barcelona, España.
Speakers:
SOMATIC ATTENTION AND PROTOCOL TO DUAL PATIENT
Maite San Emeterio, Centre d´Higiene Mental Les Corts. Barcelona, España.
HIV IN DUAL PATIENT
José Mª Vazquez, Centre d'Atenció i Seguiment de Sants. Barcelona, España.
NEUROLOGICAL COMORBIDITY IN YOUNG DUAL PATIENT
Carolina Franco, Centre d´Higiene Mental Les Corts. Barcelona, España.
10:00 – 10:45
Room 5
Book Presentation - BP01
NEW PSYCHOACTIVE DRUGS
Chair/ Speaker:
Helen Dolengevich Segal, Hospital Universitario del Henares. Madrid, España.
10:45 – 11:30
Room 5
Track: Evaluation
processes in Dual
Disorders
Workshop – WS18
DUAL DISORDERS IN MENTAL HEALTH PATIENTS
Chair:
Marcela Waisman, Fundación para la Lucha contra las Enfermedades Neurológicas de la
Infancia (FLENI). Buenos Aires, Argentina.
Speakers:
SCHIZOAFFECTIVE DISORDER AND ADDICTIONS
Marcela Waisman, Fundación para la Lucha contra las Enfermedades Neurológicas de la
Infancia (FLENI). Buenos Aires, Argentina.
SMOKING AND ADDICTIONS
Debora Serebrisky, Centro de Investigaciones Clínicas WM, Argentina.
AUTISM SPECTRUM DISORDER AND ADDICTIONS
Bettina Ortiz, Cátedra de Psiquiatría del Hospital de Clínicas, Asunción, Paraguay.
www.cipd2015.com
Pág. 48
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
10:00 – 11:30
Room 6
Track: Penitentiary
(Prisons) and Dual
Disorders
Symposium - SY55
DUAL DISORDERS IN SUBSTANCE USERS IN THE CRIMINAL JUSTICE SYSTEM - CLINICAL
COURSE AND THE EFFECT OF TREATMENT
Chair:
Anders Hakansson, Lund University. Lund, Sweden.
Speakers:
OPIATE USE AS A RISK FACTOR FOR CRIMINAL RECIDIVISM, IN-PATIENT TREATMENT AND
DEATH IN CRIMINAL JUSTICE CLIENTS - POTENTIAL FOR INTERVENTION
Anders Hakansson, Lund University. Lund, Sweden.
SUBSTANCE USE DISORDERS AND CO-MORBIDITY WITH PSYCHIATRIC DISEASE IN THE
CRIMINAL JUSTICE SETTING - POTENTIAL FOR INTERVENTION
Johan Franck, Karolinska Institute. Solna, Sweden.
RISK FACTORS FOR OVERDOSES, SUICIDES AND SELF-INFLICTED DEATH WITH
UNDETERMINED INTENT IN CRIMINALS WITH SUBSTANCE USE PROBLEMS
Martin Olsson, Lund University. Lund, Sweden.
LONG TERM RISK OF SUBSTANCE-INDUCED AND PRIMARY PSYCHOSIS AFTER RELEASE
FROM PRISON. A LONGITUDINAL STUDY OF SUBSTANCE USERS
Eline Borger-Rognli, Oslo University. Oslo, Norway.
10:00 – 11:30
Room 7
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium – SY56
DEVELOPING THE CAPABILITIES OF THE MENTAL HEALTH AND SUBSTANCE USE
TREATMENT WORKFORCE FOR DUAL DISORDERS: EXAMPLES FROM RESEARCH AND
PRACTICE
Chair:
Elizabeth Hughes, University of York. York, United Kingdom.
Speakers:
ESTABLISHING AND MAINTAINING A LOCAL DUAL DIAGNOSIS NETWORK
Elizabeth Hughes, University of York. York, United Kingdom.
LEARNING FROM SUBSTANCE USE INCIDENTS
Cheryl Kipping, Maudsley National Health Service Foundation Trust. London, United Kingdom.
MENTAL HEALTH WORKERS EXPERIENCE OF USING MOTIVATIONAL INTERVIEWING FOR
DUAL DISORDERS
Justine Trippier, National Health Service Foundation Trust. London, United Kingdom.
ESTABLISHING AND MAINTAINING A LOCAL DUAL DIAGNOSIS NETWORK
Ian Hamilton, University of York. York, United Kingdom.
10:00 – 10:45
Room 8-9
Track: Psychosis
Main Lecture – ML12
SUBSTANCE USE AND SCHIZOPHRENIA: RISK AND REWARD
Chair:
Jerónimo Sáiz, Universidad de Alcalá de Henares, Madrid, España.
Speaker:
Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA.
10:45 – 11:30
Room 8-9
Track: Alcohol
Main Lecture – ML13
PERSONALIZED TREATMENT OF ALCOHOL USE DISORDER WITH TOPIRAMATE
Chair:
Juan Gibert, Universidad de Cádiz, España.
Speaker:
Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment
Research Center. PA, USA.
www.cipd2015.com
Pág. 49
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
10:00 – 10:45
Room 10
Track: Personality
Disorders
Workshop – WS19
PSYCHOLOGICAL PROBLEMS AMONG CHILDREN WHO ARE SEXUALLY ABUSED
Chair/ Speaker:
Md.Masbah Uddin Ahmed, Bandhu Social Welfare Society. Dhaka, Bangladesh.
10:45 – 11:30
Room 10
Track: Psychosis
Workshop – WS20
TRENDS OF TISSUE SELECTION IN EPIGENETIC INVESTIGATIONS IN MAJOR PSYCHOSES:
NECESSITY FOR A UNIFIED FRAMEWORK IN PSYCHIATRIC EPIGENETIC STUDIES?
Bahar Massih, Tarbiat Modares University, Bahar Medical Laboratory. Tehran, Iran.
CANCELLED
10:00 – 10:45
Room 11
Track:
Psychopharmacological
Treatments in Dual
Disorders
Workshop – WS21
PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL DISORDERS: THE CASE OF
SCHIZOPHRENIA AND SUBSTANCE ABUSE
Chair:
Luis A. Núñez, Centro Médico de Diagnóstico. Pamplona, Navarra, España.
Speakers:
PALIPERIDONE PALMITATE IN DUAL DIAGNOSIS. A RETROSPECTIVE STUDY
Luis A. Núñez, Centro Médico de Diagnóstico de Pamplona. Navarra, España.
CURRENT TENDENCIES IN PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL PATHOLOGY
María García, Centro Salud Mental de Tudela. Navarra, España.
SCHIZOPHRENIA AND COMORBID SUBSTANCE ABUSE. AN UPDATE
Olga Arbeo, Centro de Día Zuría, Pamplona. Navarra, España.
10:45 – 11:30
Room 11
Track: Multidisciplinary
Intervention in Dual
Disorders
Workshop - WS22
DUAL DISORDERS: NEW PROBLEMS, NEW SOLUTIONS
Chair:
Juan J. Hernández, Cruz Roja Española. Madrid, España.
Speakers:
MULTI-CHANNEL INFORMATION AND DRUG PREVENTION SERVICE OF SPANISH RED CROSS
Cristina Ferrero, Cruz Roja Española. Madrid, España.
PREVENTION SERVICE AND TREATMENT OF ADDICTION TO TECHNOLOGY
Silvia Allué, Asociación Punto Omega, Móstoles. Madrid, España.
POST-DISCHARGE MONITORING PROGRAM OF THE SPANISH RED CROSS
Juan J. Hernández, Cruz Roja Española. Madrid, España.
10:00 – 11:30
Room 12
Oral Communications - OC10
Chairs:
Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d’Hebron, Barcelona,
España.
Florence Vorspan, Publique-Hôpitaux de Paris, France.
POST HOC ANALYSES OF THE EFFICACY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS
PREVIOUSLY TREATED WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER MEDICATION
1
2
2
3
L.A. Adler, J. Wu, M. Madhoo, B. Caballero
1
New York University School of Medicine, New York, NY, USA.
2
Shire, Wayne, PA, USA.
3
Shire, Zug, Switzerland.
www.cipd2015.com
Pág. 50
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
INTEGRATIVE PROGRAM MODEL [IPM]: DIALECTICAL BEHAVIOR AND
PSYCHODYNAMICALLY INFORMED GROUP PSYCHOTHERAPY
Claudia Arlo
Addiction Institute of NY, Mt Sinai Roosevelt Hosp./Fordham University. NY, USA.
ANXIETY IN ADDICTIONS
Antonio Domingo Pisano
Hospital J.T. Borda, Buenos Aires, Argentina.
ANXIETY DISORDERS ARE ASSOCIATED WITH EARLY ONSET OF HEROIN USE AND RAPID
TRANSITION TO DEPENDENCE IN METHADONE MAINTAINED PATIENTS
1
1
2
1
1
Emily Karsinti , Vanessa Bloch , Jan Scott , Jean Pierre Lépine , Frank Bellivier , Florence
1
Vorspan
1
APHP - Hôpital Fernand Widal, Paris, France.
2
Institute of Neuroscience, Newcastle University; Centre for Affective Disorders, Institute of
Psychiatry, London, United Kingdom.
ASSESSMENT OF DEPRESSION AND ANXIETY IN PATIENTS WITH TREATED AND UNTREATED
RESISTANT HYPERTENSION: A PILOT STUDY
1
2
1
1
3
4
A.Mermerelis , A. Douzenis , S-M Kyvelou , Vellinga A , C. Stefanadis , C. Papageorgiou
1
Galway University Hospital , Ireland.
2
2nd psychiatry clinic Athens University, Greece.
3
1st cardiology clinic Athens University, Greece.
4
1st psychiatry clinic Athens University, Greece.
PERSONALITY CHARACTERS AND TENDENCY TO ADDICTION: A COMPARATIVE STUDY
BETWEEN ADDICTED AND NONADDICTED PEOPLE
1
2
3
Gholamali Nikpour , Alireza Homayouni , Arsalan Khanmohammadi Otaghsara , Seyed Jalal
4
Mosavi Amiri
1
Allameh Tabatabaii University, Tehran, Iran.
2
College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran.
3
College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran.
4
Medical Clinic of Dr. Mosavi, Amirkola, Iran.
ANXIETY AND ALCOHOL CONSUMPTION
1,2
1
1,2
Delia Marina Podea , Karol-Julien Wild , Ionela Natalia Cotos
1
“Vasile Goldis” Western University of Arad -Psychiatry Department, Romania.
2
County Clinical Emergency Hospital of Arad- Psychiatry Department, Romania.
BORDERLINE PERSONALITY DISORDER AND SUBSTANCE USE DISORDER: ARE THEY A REAL
COUPLE?
1
2
1
1
1
T. Sousa-Ferreira , M. Ferreira , S. Ferreira , J. Amaral , T.Cabral
1.
Department of Psychiatry And Mental Health - Centro Hospitalar Tâmega e Sousa, Penafiel,
Portugal.
www.cipd2015.com
Pág. 51
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
2.
Department of Psychiatry And Mental Health – Hospital de Braga, Braga, Portugal.
PROFESSIONALS WORKING WITH PATIENTS WITH ATTACHMENT DISORDER AND DUAL
DIAGNOSIS- HOW TO NAVIGATE IN PROJECTIVE IDENTIFICATIONS
C. Madsen, A.L.Kronborg
Municipality of Skanderborg, Skanderborg, Denmark.
11:30 – 13:00 h.
11:30 – 12:15
Room 2
Track: Depression
Main Lecture - ML14
DEPRESSION AND DUAL DISORDERS
Chair:
J. Manuel Menchón, Hospital Universitari de Bellvitge. Barcelona, España.
Speaker:
Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat
Autònom, Barcelona, España.
12:15 – 13:00
Room 2
Track: Suicide & Dual
Disorders
Main Lecture - ML15
SUICIDE
Chair:
Lucas Giner, Universidad de Sevilla. Sevilla, España.
Speaker:
Leo Sher, Mount Sinai School of Medicine/James J. Peters Veterans’ Administration Medical.
NY, USA.
CANCELLED
11:30 – 13:00
Room 3
Track:
Psychopharmacological
Treatments in Dual
Disorders
Symposium – SY57
DUAL PATHOLOGY TREATMENT IN DRUG ADDICTION CENTERS
Chair:
Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España.
Speakers:
ANXIETY-DEPRESSION DISORDERS IN ALCOHOLIC PATIENTS. A PERSPECTIVE FROM A CAD
(DRUG ADDICTION TREATMENT CENTER)
Pilar San Juan, Centro de Atención a Las Drogodependencias de Villaverde. Madrid, España.
USE OF ATYPICAL ANTIPSYCHOTICS IN DUAL DIAGNOSIS
Dolores Baño, Centro de Atención a Drogodependencias de Majadahonda. Madrid, España.
OPIOID SYSTEM IN PATIENTS WITH BORDERLINE PERSONALITY DISORDER THAT ARE
GOING TO DRUG ADDICTS CARE CENTER FOR ALCOHOL AND OPIOID DEPENDENCE
Rocío Molina, Centro de Atención a Las Drogodependencias de Arganzuela. Madrid, España.
11:30 – 13:00
Room 4
Track: Planning,
regulations and
resource management
Invited Symposium – IS16
INTEGRATED RESOURCES IN DUAL DISORDERS
Chair:
Luis Alfonzo B., Organización Panamericana de la salud, Washington, DC, USA.
Speakers:
ADMISSION UNITS IN DUAL PATHOLOGY
Célia Franco, Unidade de Patologia Dual, Centro Hospitalar Universitário de Coimbra,
www.cipd2015.com
Pág. 52
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Portugal.
RESOURCES IN DUAL PATHOLOGY
Carlos Roncero, Universidad Autónoma de Barcelona, España.
EVOLUTION AND CURRENT STATUS OF THE DUAL PATHOLOGY IN MEXICO
Jorge Ocampo, Mexican Academy of Dual Pathology (AMEPAD), Mexico.
MANAGEMENT OF DUAL INTEGRAL PATHOLOGY IN PSYCHIATRIC HOSPITAL IN MEXICO
Juan Rosales, Mexican Academy of Dual Pathology, Mexico.
11:30 – 12:15
Room 5
Track: Basic research
in Dual Disorders
Workshop - WS23
CONCISE EMOTIONAL INTEGRAL TREATMENT PROGRAM IN DUAL DISORDERS: A PILOT
STUDY
Chair:
Araceli García, Investigación Psicológia en UNED. Madrid, España.
Speakers:
Araceli García, Investigación Psicológia en UNED. Madrid, España.
Vicent Plá, Proyecto Hombre de Gandía. Comunidad Valenciana, España.
12:15 – 13:00
Room 5
Track: Multidisciplinary
Intervention in Dual
Disorders
Workshop - WS24
UPDATING THE APPROACH TO DUAL PATIENTS AT THE GENERAL HOSPITAL
Chair:
Francisco J. Quintero, Hospital Universitario Infanta Leonor. Madrid, España.
Speakers:
SOMATIC COMORBIDITY IN DUAL PATIENT
Fernando Mora, Hospital Infanta Leonor. Universidad de Alcalá. Madrid, España.
ADDRESSING THE TURMOIL IN THE DUAL PATIENT
Javier Correas, Hospital Universitario del Henares. Madrid, España.
HCV AS A MARKER OF SEVERITY IN PATIENTS WITH DUAL DIAGNOSIS
Helen Dolengevich, Hospital Universitario del Henares. Madrid, España.
11:30 – 13:00
Room 6
Track: Psychosis
New Forum - NF02
THE COLORFUL SPECTRUM OF DUAL DISORDERS
Chair:
Arnt Schellekens, Radboud University, Nijmegen Institute for Scientist Practitioners in
Addiction. Nijmegen, The Netherlands.
Speakers:
ALTERED REWARD PROCESSING DEFICITS IN ADHD AND CO-OCCURRING SUBSTANCE USE
DISORDERS
Arnt Schellekens, Radboud University, Nijmegen Institute for Scientist Practitioners In
Addiction. Nijmegen, The Netherlands.
DEMORALIZATION IN DUALLY DIAGNOSED PATIENTS
Gerdien de Weert, Radboud University, Nijmegen Institute for Scientist Practitioners In
Addiction. Nijmegen, The Netherlands.
PSYCHOTRAUMA AND ADDICTION
Tim Kok, Tactus Addiction Treatment. Enschede, The Netherlands.
ACUTE AND CHRONIC EFFECTS OF CANNABINOIDS ON BRAIN: PATHWAYS TO PSYCHOSIS
www.cipd2015.com
Pág. 53
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Albert Batalla, Tactus Addiction Treatment. Deventer, The Netherlands.
DUAL DIAGNOSES IN A SAMPLE OF SEVERELY CRIMINAL FEMALE OFFENDERS
Eric Blaauw, Verslavingszorg Noord Nederland (VNN). Groningen, The Netherlands.
PSYCHOPATHOLOGY AMONG GHB USERS
Rama Kamal, Novadic-Kentron Addiction Care Netwerk. Vught, The Netherlands.
11:30 – 13:00
Room 7
Track: Multidisciplinary
Intervention in Dual
Disorders
Symposium – SY58
HOW TO TREAT DUAL PATIENTS: EXPERIENCE OF DUAL PATHOLOGY UNITS
Chair:
António G. da Silva, Associaçâo Brasileira de Psiquiatria. Rio de Janeiro, Brasil.
Speakers:
EVALUATION OF TREATMENT IN A DUAL PATHOLOGY UNIT, ADDICTION INSTITUTE OF
MADRID SALUD
Diego Urgelés, Clínica Nuestra Señora de La Paz. Madrid, España.
TREATMENT PHASES IN DUAL PATIENTS
Vera Martins, Unidade Patologia Dual. C.H.U. Coimbra, Portugal.
PHARMACOLOGICAL INTERVENTIONS IN DUAL PATIENTS
Tânia Silva, Centro Hospitalar Universitario de Coimbra, Portugal.
MULTIDISCIPLINARY TEAM IN DUAL PATIENT'S TREATMENT
Cândida Henriques, Centro Hospitalar Universitário de Coimbra, Portugal.
11:30 – 13:00
Room 8-9
Track: Behavioral
addictions / Gambling
Disorders
Symposium – SY59
PATHOLOGICAL GAMBLING, INTERNET ADDICTION AND THE INTRIGUING FLASHBACK:
DECIPHERING THE CHALLENGING PUZZLE
Chair:
Arturo G. Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv,
Israel.
Speakers:
GENDER DIFFERENCES AND DUAL DIAGNOSIS IN PATHOLOGICAL GAMBLERS
Pinhas Dannon, Beer Yaakov-Ness Ziona MHC, Sackler School of Medicine Tel Aviv University.
Tel Aviv, Israel.
FLASHBACKS (FB) AND HALLUCINOGEN PERSISTING PERCEPTION DISORDER (HPPD):
CLINICAL TOPICS AND TREATMENT APPROACH
Arturo G. Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv,
Israel.
COMORBIDITY OF INTERNET ADDICTION WITH OTHER PSYCHIATRIC CONDITIONS
Aviv Weinstein, University of Ariel. Ariel, Israel.
11:30 – 12:15
Room 10
Track: Multidisciplinary
Intervention in Dual
Disorders
Workshop - WS25
SUBSTANCE USE & INTELLECTUAL DISABILITY
Chair:
Joanne E.L. Van Der Nagel, Tactus Addiction Treatment. Deventer, The Netherlands.
Speakers:
www.cipd2015.com
Pág. 54
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
SUBSTANCE USE AMONG PERSONS WITH ID; DIAGNOSIS AND ASSESSMENT, CASE
COORDINATION AND OUTPATIENT SERVICES
Joanne Van Der Nagel, Tactus Addiction Treatment. Deventer, The Netherlands.
SUBSTANCE USE AMONG PERSONS WITH ID; AN INPATIENT TREATMENT PROGRAM
Fleur Vruwink, Tactus Addiction Care. Deventer, The Netherlands.
12:15 – 13:00
Room 10
Track: Behavioral
addictions / Gambling
Disorders
Workshop – WS26
UPDATE ON PATHOLOGICAL GAMBLING AND DUAL PATHOLOGY MANAGEMENT
Chair:
César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis
Ortega en la Isla de Margarita, Venezuela.
Speakers:
César A. Sánchez-Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis
Ortega en la Isla de Margarita, Venezuela.
Irene Chitty, Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita,
Venezuela.
11:30 – 13:00
Room 11
Track: Personality
Disorders
Symposium – SY60
PERSONALITY AND ADDICTION: NEW ADVANCES, NEW CONTROVERSIES
Chair:
Lola Peris, Centre Neuchâtelois de Psychiatrie (CNP), Neuchâtel, Switzerland.
Speakers:
PERSONALITY, PERSONALITY DISORDERS AND ADDICTION: THE ISSUES OF THEIR
NEUROBIOLOGICAL LINK
Lola Peris, Centre Neuchâtelois de Psychiatrie (CNP), Neuchâtel, Switzerland.
MUST WE WAIT TO DIAGNOSE DUAL PERSONALITY DISORDERS?
Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio
Marañón. Madrid, España.
USE OF SUBSTANCES AND SUICIDE: THE ROLE OF PERSONALITY TRAITS
Víctor Pérez-Sola, CIBERSAM / Hospital del Mar, Barcelona, España.
11:30 – 13:00
Room 12
Oral Communications - OC11
Chairs:
Mar Ramos, Hospital Universitari Vall d'Hebron. Barcelona, España.
Yenny Saad, Faculta de Medicina de la Universidad de la República del Uruguay, Uruguay.
POLY-DRUG USE AND MENTAL DISTRESS COMORBIDITY:
A 10-YEAR PROSPECTIVE STUDY OF PATIENTS FROM SUBSTANCE ABUSE TREATMENT IN
NORWAY
J. Burdzovic Andreas, G. Lauritzen, T. Nordfjærn
Norwegian Institute for Alcohol and Drug Research (SIRUS), Oslo, Norway.
TOBACCO USE AND BIPOLAR DISORDER. THE BRIEF INTERVENTION AT COMMUNITY
MENTAL HEALTH
V. Millán Aguilar Rodríguez, C. García Caro, M. Ayora Rodrírguez, E. Rodríguez Jimenez, A.
www.cipd2015.com
Pág. 55
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Ruiz Arcos, A. Padilla Mata, M. Ordovás Gonzalez, L. Asensio Aguerri, E. Prieto Bonilla, F.
Sarramea Crespo
Hospital Universitario Reina Sofía, Córdoba, España.
BIPOLAR DISORDER AND SUBSTANCE USE DISORDER COMORBIDITY: CYCLOTHYMIC
ENDOPHENOTYPE
1
1
1
2
S. Kesebir , O. Noyan , S. Nurmedov , A.E. Darcin
1
Uskudar University, Istanbul, Turkey.
2
Kanuni State Hospital, Istanbul, Turkey.
DISPARITIES IN ACCESS AND EFFECTIVENESS FOR EVIDENCE-BASED SUPPORTED
EMPLOYMENT FOR PERSONS WITH CO-OCCURRING SERIOUS MENTAL ILLNESS (SMI) AND
SUBSTANCE USE DISORDER (SUD): EVIDENCE FROM A STATE-WIDE POLICY INTERVENTION
1
2
3
2
David Salkever , Brent Gibbons , Michael Abrams , Kevin Baier
1
The School of Public Policy at the University of Maryland-Baltimore County (UMBC); Johns
Hopkins-Bloomberg School of Public Health, Johns Hopkins University. MA, USA.
2
Maryland Institute for Policy Analysis and Research and the School of Public Policy, UMBC.
MA, USA.
3
Hilltop Institute and the School of Public Policy, UMBC. MA, USA.
EFFECT OF TOBACCO ABSTINENCE AND BUPROPION AUGMENTATION ON COGNITIVE
FUNCTION IN SCHIZOPHRENIC PATIENTS: A DOUBLE-BLIND PLACEBO AND CONTROLLED
STUDY
1,2
1.2
1.2
Najmeh Shahini , Mansoreh Mirzadeh , Mohammad Reza Fayyazi Bordbar
1
Psychiatry and Behavioural Sciences Research Center, Ibn-e-Sina Hospital, Faculty of
Medicine. Mashhad, Iran.
2
Mashhad University of Medical Sciences, Mashhad, Iran.
PSYCHOSIS AFTER OPIOD WITHDRAWAL – ARE OPIOID DRUGS ANTYPSYCHOTICS?
1
2
1
V. Vila Nova , C. Oliveira , C. Cotta
1
Centro Hospitalar Barreiro-Montijo, Barreiro, Portugal.
2
Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal.
NEUROBEHAVIORAL ASPECTS OF OMEGA-3 FATTY ACIDS: POSSIBLE MECHANISM AND
THERAPEUTIC VALUE IN DUAL DIAGNOSIS
S. Rabinovitz
University of Haifa, Haifa, Israel.
NEUROCOGNITIVE CHARACTERISTICS OF PSYCHOTIC SYMPTOMS IN YOUNG ADULTS WITH
HIGH FUNCTIONING AUTISM
1,2
3
1,2
R. Rinaldi , E. Jacquet , L. Lefebvre
1
Neuropsychology and Cognitive Sciences Department, University of Mons, Belgium.
2
UMONS Research Institute for Health Sciences and Technology, University of Mons,
Belgium.
3
Faculty of Psychology and Educational Sciences, University of Mons, Belgium.
www.cipd2015.com
Pág. 56
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
POLITICS AND ECONOMICS OF METHADONE IN RURAL CANADA
1
2
Sanjay Siddhartha , Ajay Wagle
1
Miramichi Hospital, Miramichi, Canada.
2
Norwich NHS Trust, Canada.
13:00 – 14:30 h.
13:00 – 14:30
Room 2
Track:
Psychopharmacological
Treatments in Dual
Disorders
Symposium – SY61
PARKINSON'S DISEASE, HEADACHE AND CHRONIC FATIGUE SYNDROME: EXPLANATORY
MODELS OF NEUROBIOLOGICAL MECHANISMS OF SUBSTANCE USE DISORDERS
Chair:
Luis Sánchez Planell, Universidad Autónoma de Barcelona, España.
Speakers:
DISORDERS OF IMPULSE CONTROL AND DOPAMINE DYSREGULATION SYNDROME IN
PARKINSON'S DISEASE
Naia Sáez-Francàs, Hospital Vall d'Hebron. Barcelona, España.
IS PERSONALITY A FACTOR INVOLVED IN THE APPEARANCE OF CHRONIC FATIGUE
SYNDROME AND ITS RELATION TO SUBSTANCE USE DISORDERS?
Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona,
España.
HEADACHE AND MISUSE OF MEDICATION
Patricia Pozo, Servicio de Neurología, Hospital Vall d´Hebron, Barcelona, España.
13:00 – 14:30
Room 3
Track: Epidemiology
and Dual Disorders
Symposium - SY62
RESULTS FROM THE CO-OCCURRING DISORDERS MULTICENTER STUDY IN MEXICAN
RESIDENTIAL CENTERS
Chair:
Rodrigo Marin-Navarrete, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz.
Ciudad de México, México.
Speakers:
CO-OCCURRING DISORDERS IN RESIDENTIAL CENTERS A PUBLIC HEALTH CONCERN IN
MEXICO
Rodrigo Marin-Navarrete, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz.
Ciudad de México, México.
LATENT CLASS PROFILE OF SEXUAL RISK BEHAVIOR AND CO-OCCURRING DISORDERS IN A
SAMPLE OF RESIDENTIAL PATIENTS
Luis Villalobos-Gallegos, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz,
Universidad Autonómica Nacional. Ciudad de México, México.
PREVALENCE AND CORRELATES OF CO-OCCURRING DISORDERS IN A FEMALE SUB-SAMPLE:
A SECONDARY ANALYSIS
Ana de la Fuente, Universidad La Salle. Ciudad de México, México.
13:00 – 14:30
Room 4
Invited Symposium - IS17
DUAL DISORDERS: NEW PHARMACOLOGICAL TREATMENTS
www.cipd2015.com
Pág. 57
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Track:
Psychopharmacological
Treatments in Dual
Disorders
Chair:
Diego Palau, Corporació Sanitaria i Unviersitari Parc Taulí, Sabadell. Barcelona, España.
Speaker:
VARENICLINE IN SMOKING CESSATION THROUGH SMOKING REDUCTION
Eugeni Bruguera, Hospital Universitari Vall d'Hebron. Barcelona, España.
PHARMACOLOGICAL ADVANCES IN THE MODULATION OF NICOTINIC CHOLINERGIC
SYSTEMS: THERAPEUTIC IMPLICATIONS IN DUAL PATHOLOGY
Cecilio Álamo, Universidad de Alcalá, Hospital de la Paz, España.
ADDRESSING TOBACCO CESSATION IN AN INPATIENT ADDICTION UNIT
Mª Cristina Pinet, Hospital de la Santa Creu i Sant Pau. Barcelona, España.
13:00 – 14:30
Room 5
Track: Attention Deficit
Symposium - SY63
DIFFERENTIAL ASPECTS IN ADULTS WITH ‘ADHD’ IN DIFFERENT SUBSTANCE USE
DISORDERS
Chair:
José R. Gutiérrez, Hospital Perpetuo Socorro. Badajoz, España.
Speakers:
TRANSLATIONAL ASPECTS AND CLINICAL UTILITY OF MANAGEMENT OF ADHD IN ADULTS
WITH SUD BY DIFFERENT TYPES OF SUBSTANCES
José R. Gutiérrez, Hospital Perpetuo Socorro. Badajoz, España.
GENERAL AND SPECIFIC FREQUENCY OF ADHD IN A SAMPLE OF ADULT PATIENTS WITH SUD
BY DIFFERENT TYPES OF SUBSTANCES: ANALYSIS OF THE SAMPLE.
José M. Zoido, Centro Extremeño de Atención a la Drogodependencia. CEDEX. Badajoz,
España.
INFLUENCES OF AFFECTIVE VARIABLES IN THE ASSESSMENT OF ADHD IN A SAMPLE OF
ADULTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES
Francisco J.R.Pino, Unidad de Salud Mental de Montijo. Badajoz, España.
13:00 – 14:30
Room 6
Track: Legal aspects in
Dual Disorders
Symposium – SY64
THREE REALITIES IN A SINGLE PATIENT IN HEALTHCARE SERVICES FOR DRUG ADDICTION
AND DUAL PATHOLOGY
Chair:
Isabel Aguilar, Santa Cruz de Tenerife, España.
Speakers:
THE NEED FOR A STRATEGY AND COORDINATION HEALTH PLAN FOR DUAL PATHOLOGY AT
THE MURCIAN HEALTH SERVICE
Desiderio Mejías, Hospital de la Vega Lorenzo Guirao, Cieza. Murcia, España.
APPROACH TO DUAL DIAGNOSIS IN ANDALUSIA: "A CLINICAL ENTITY, TWO HEALTHCARE
NETWORKS
Juan Ramírez, Servicio Provincial Drogodependencias y Adicciones Huelva, España.
DEPENDENCE OF DRUG ADDICTIONS ON SUBSIDY POLICIES IN THE CANARIES.
REGULATIONS AND ISSUES
Isabel Aguilar, Santa Cruz de Tenerife, España.
www.cipd2015.com
Pág. 58
Monday April 20th
13:00 – 14:30
Room 8-9
Track: Gender and Dual
Diagnosis
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
Symposium - SY65
DUAL DISORDERS IN A TRANSSEXUALITY AND GENDER IDENTITY UNIT FROM THE PUBLIC
HEALTH SERVICE. RESEARCH, MANAGEMENT AND INTERVENTION
Chair:
Pedro M. P. Matos, Hospital Regional Universitario de Málaga. Málaga, España.
Speakers:
RESEARCH ABOUT SUBSTANCE CONSUMPTION AND MENTAL HEALTH FROM THE
MINORITY STRESS MODEL PERSPECTIVE
José Gúzman, Hospital Regional Universitario de Málaga. Instituto de Investigación
Biomédica. Málaga, España.
VICTIMIZATION AND VIOLENCE AND ITS RELATION WITH SUBSTANCE USE IN
TRANSSEXUALS
Pedro M. Paulino Matos, Hospital Regional Universitario de Málaga. Málaga, España.
SUBSTANCE USE AND SUICIDAL BEHAVIORS IN TRANSSEXUALS' INDIVIDUALS
Lucía Pérez, Hospital Regional Universitario de Málaga. Universidad de Málaga. Málaga,
España.
13:00 – 14:30
Room 12
Oral Communications - OC12
Chairs:
Josep Salavert, Hospital San Rafael, Barcelona, España.
Mariano Montenegro, Universidad de Chile, Santiago, Chile.
DOES DRUG-INDUCED PSYCHOSIS REALLY EXIST?
1
2
3
Luis Alfonso Núñez Domínguez , María García Nicolas , Olga Arbeo Ruiz
1
Centro Médico. España.
2
Centro Salud Mental Tudela. España.
3
Centro de Día Zuría. España.
AGE RELATED EFFECTS ON COGNITIVE FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA
AND COCAINE DEPENDENCE
1
1,2
1,3
I.Benaiges , J.M. Serra-Grabulosa , A. Adan
1
Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona,
España.
2
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, España.
3
Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España.
CLINICAL FEATURES OF SCHIZOPHRENIA IN PERSONS USING NARCOTIC SUBSTANCES OF
THE OPIUM ROW
1
1
2
1
N.A. Bokhan , A.V. Semke , A.P. Sidenkova , A.F. Abolonin
1
Mental Health Research Institute SB RAMSci, Tomsk, Russia.
2
Ural State Medical University, Yekaterinburg, Russia.
TOXIC PSYCHOSIS VS DUAL PATHOLOGY: LONGITUDINAL EVALUATION OF PATIENTS
ADMITTED TO THE PSYCHIATRY DEPARTMENT OF HOSPITAL GARCIA DE ORTA
www.cipd2015.com
Pág. 59
Monday April 20th
PRELIMINARY PROGRAM - UPDATED: 19/04/2015
S. Coelho, A. Roberto, D. Sennfelt
Hospital Garcia de Orta, Lisbon, Portugal.
ZIPRASIDONE VS. CLOZAPINE IN THE TREATMENT OF DUALLY DIAGNOSED (DD) PATIENTS
WITH SCHIZOPHRENIA AND CANNABIS USE DISORDERS: A RANDOMIZED STUDY
1,2
1,3
E. Gouzoulis-Mayfrank , T. Schnell
1
University Hospital of Cologne, Cologne, Germany.
2
LVR Clinics Cologne, Cologne, Germany.
3
Medical School Hamburg (MSH), Hamburg, Germany.
TREATING PSYCHOTIC PATIENTS WITH AGONIST OPIOID THERAPY AND ATYPICAL
ANTIPSYCHOTICS
Maria Chiara Pieri
Drug Addiction Unit Bologna, Italy.
GENDER DIFFERENCES IN RETENTION IN DUALLY DIAGNOSED ADULTS ATTENDING PRIVATE
RESIDENTIAL TREATMENT IN THE U.S.
Siobhan Morse
Foundations Recovery Network, Brentwood, TN. USA.
PSYCHOLOGICAL, ENVIRONMENTAL OR PHYSICAL FACTORS, WHICH IS THE FIRST CAUSE OF
TENDENCY TO ADDICTION?
1
2
3
Seyed Jalal Mosavi Amiri , Alireza Homayouni , Gholamali Nikpour , Arsalan
4
Khanmohammadi Otaghsara
1
Medical Clinic of Dr. Mosavi, Amirkola, Iran.
2
College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran.
3
Allameh Tabatabaii University, Tehran, Iran.
4
College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran.
www.cipd2015.com
Pág. 60
www.cipd2015.com
Pág. 61
PARALLEL ACTIVITIES
th
Thursday, April 16
09:00 – 18:00
SEPD Meeting Room
th
Friday, April 17
09:00 – 16:00
SEPD Meeting Room
NIDA RESEARCH PROJECT MEETING: INTERNATIONAL LATINO RESEARCH PARTNERSHIP
By invitation only
Margarita Alegría, Center for Multicultural Mental Health Research, Cambridge Health
Alliance & Harvard Medical School, Somerville. MA, USA.
Enrique Baca, Fundación Jiménez Díaz, Madrid, España.
Francisco Collazos, Hospital Universitari Vall d'Hebron, Barcelona, España.
Sociedad Española de Patología Dual SEPD
FOUNDATION ACTIVITIES
Friday, April 17th
16:45 – 17:30
Room 11
DUAL PATHOLOGY AND ART
Co-organized by the Foundation on Dual Disorders
Chair:
Lara Grau-López, Hospital Universitari Vall d’Hebron. Barcelona, España.
Speaker:
J. Ramon Pigem, Clínica Bellavista, Lleida, España.
Friday, April 17th
16:00 – 18:00
Room 13
Foundation on Dual Disorders
FEAFES
CROSSROADS OF DUAL PATHOLOGY: THE VISION OF ASSOCIATIONS OF PEOPLE WITH
MENTAL ILLNESS AND THEIR FAMILIES
Chairs:
Pablo Vega, Sociedad Española de Patología Dual (SEPD); Instituto de Adicciones. Madrid,
España.
Nel Anxelu González, Confederación Española de Agrupaciones de Familiares y Personas con
Enfermedad Mental (FEAFES), España.
Speakers:
José Mª Vázquez, CAS de Sants, Barcelona, España.
Lina Mª Huertas, Confederación FEAFES, España.
Rosario Tomás, CRIS de la asociación AFEPVI, Villena, Alicante, España.
David Soriano, CRIS de la asociación AFEPVI, Villena, Alicante, España.
Friday, April 17th,
Saturday, April 18th
SURVEY ON USE OF TOBACCO ON PROFESSIONALS
Sponsored by the Foundation on Dual Disorders
Coordinated by:
Fernando W. Müller, Centro de Investigaciones Clínicas WM. Argentina.
Debora Serebrisky, Centro de Investigaciones Clínicas WM. Argentina.
Diana Romero, Hospital Universitario Vall d'Hebron. SEPD. España.
Alfonso Abad, Hospital Universitario Vall d'Hebron. SEPD. España.
Saturday, April 18th
14:00 – 16:00
PROMOTION OF THE RESEARCH NETWORKS WITH CLINICAL AND PREVENTIVE
APPLICATION. ACTION 29 OF THE PND
www.cipd2015.com
Pág. 62
SEPD Meeting Room
CANCELLED
th
Saturday, April 18
Room 9
By invitation only
Chair:
Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid,
España.
Speakers:
José Oñorbe, Delegación del Gobierno del Plan Nacional sobre Drogas, Madrid, España.
Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España.
María Estrada, Subdirecció General de Drogodependències, Barcelona, España.
Medical Educational Room
Sponsored by the Foundation on Dual Disorders
Language: English
INFORMATION FOR PATIENTS ON INTERNET: QUALITY RESOURCES AND BLOG CREATION
PUBMED – ALERTS
ZOTERO. CITATION MANAGEMENT SOFTWARE
08:30 – 09:10
09:15 – 09:55
14:00 – 14:40
Language: Spanish
PUBMED – ALERTAS
ZOTERO. GESTOR DE REFERENCIAS BIBLIOGRÁFICAS
INFORMACIÓN PARA PACIENTES EN INTERNET: RECURSOS DE CALIDAD Y CREACIÓN DE
BLOGS
14:45 – 15:25
15:30 – 16:10
16:15 – 16:55
th
Sunday, April 19
Room 9
09:15 – 09:55
Language: English
INFORMATION FOR PATIENTS ON INTERNET: QUALITY RESOURCES AND BLOG CREATION
12:00 – 12:40
12:45 – 13:25
13:30 – 14:10
Language: Spanish
PUBMED – ALERTAS
PUBMED – FILTROS PERSONALIZADOS
ZOTERO. GESTOR DE REFERENCIAS BIBLIOGRÁFICAS
14:15 – 14:55
15:00 – 15:40
Language: English
PUBMED – ALERTS
ZOTERO. CITATION MANAGEMENT SOFTWARE
15:45 – 16:25
www.cipd2015.com
Language: Spanish
INFORMACIÓN PARA PACIENTES EN INTERNET: RECURSOS DE CALIDAD Y CREACIÓN DE
BLOGS
Pág. 63

Nota de prensa - Banco de España

Table 1.6 - Banco de España

1 Motortec15FileSheet

Latest Programme Women in Science Seminar

Supplementary appendix

General Information - Real Federación Española de Salvamento y

7 MB - Bioiberica

JOB POSTING

Leer mas... - Universidad Complutense de Madrid

Product datasheet 9241380 KOMBIC 4000 LM NW WH. Description

avm bull. Feb 2015 - Jim Harries Mission

MODULAR SLIM

Host Institution – Universided Central de Venezuela

Agenda

ANECA Plantilla Folio

Product datasheet 7241302 IMAG TRACK 1300LM WW SPOT

UPM ATHENS Programme Arrival - Universidad Politécnica de Madrid

to view the CHSE PowerPoint Presentation (PDF Format)

CV - Andrés Villa Torres

Product datasheet 9202650 KONIC 2X26W G24d

Version 15.03.1 P V March, 2015.